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Bacteria inhabit most environments including the bodies of plants and animals. Protein 
secretion plays an important role in modulating the way bacteria interact with their 
environment. Bacteria have developed several different secretion systems to secrete the 
proteins across their own cell membrane and into the host cell cytoplasm. The secreted 
proteins help the bacteria to survive in these harsh environments and facilitate the host-
pathogen interactions to cause the infection. To date seven different secretion systems 
(Type I to Type VII) have been identified. This thesis reports the structure and function 
of a type III regulatory complex and of a type IV recruitment protein. A detailed 
introduction of the bacterial secretion systems is given in Chapter1.  
Attaching and effacing (AE) pathogens like the enterohemorrhagic Escherichia 
coli (EHEC) and enteropathogenic E. coli (EPEC) possess type III secretion systems 
(T3SS) that promote virulence. Most T3SS components and related proteins are encoded 
by genes in the locus of enterocyte effacement (LEE). The LEE consists of 41 genes, 
clustered in five different operons, termed LEE1-LEE5, and some additional transcription 
units. The LEE genes encode type III secretion system (T3SS) proteins and three 
associated regulators: Ler, GrlA and GrlR. Ler is a positive regulator for most of the LEE 
operons, including grlRA. GrlA controls the expression of ler, ehxCABD and flhDC 
operons. GrlR binds to GrlA and suppresses its function.  
 In chapter II, we report the crystal structure of GrlR-GrlAΔ (aa 1-106) complex 
(2:1) and its functional characterization.  We show that GrlR interacts with the Helix-
Turn-Helix (HTH) motif of GrlA. Moreover, GrlA binds to the promoter DNA fragments 




for the HTH motif of GrlA. These findings provide mechanistic insight into a novel 
regulatory module for EPEC and EHEC virulence, two important pathogens that cause 
devastating diseases. 
Type IV secretion system (T4SS) is the only bacterial secretion system known to 
translocate DNA in addition to protein substrates. T4SS translocate DNA not only to 
other bacteria but also to higher eukaryotic organism in a contact dependent manner. 
VirB/D4 system of Agrobacterium tumefaciens is a typical example of T4SS. The 
proteins involved in translocation include, the DNA processing and packaging proteins, 
the VirB secretion system apparatus proteins and the VirD4 coupling protein. VirD2 
binding protein (VBP) is a cytoplasmic protein that plays a key role in recruiting the T-
DNA-protein complex to the VirD4 coupling protein. Thus VBP is an important protein 
in the T4SS translocation pathway. 
 In chapter III, we report the crystal structure of the C-terminal domain of VBP 
along with the biophysical and in vivo functional studies. Sequence and structural 
analysis shows that the C-terminal domain is homologous to the HEPN domain of Sacsin 
protein. Biophysical experiments reveal that VBP is a dimer in solution and HEPN 
domain (C-terminal domain) is the dimerization domain of VBP. Furthermore, the in vivo 
functional studies with full length VBP have shown that only dimeric VBP can recruit the 
T-DNA-protein complex to the VirD4 coupling protein and lead to tumor formation. This 
study sheds light on the function of VBP in the recruiting complexes and thus widens the 
understanding of T4SS pathway in A.tumefaciens as well as in many pathogenic bacteria 
such as Bartonella, Bordetella, Legionella and other species which have homologous 
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1.1. Bacterial Secretion Systems 
 
Bacteria are among the first life forms on earth. They inhabit most environments 
including  the bodies of plants and animals, acidic hot springs, earth's crust, organic 
matter and even radioactive waste, providing outstanding examples of mutualism. They 
cause a vast number of diseases in humans, plants and animals. Protein secretion plays an 
important role in modulating the way the bacteria inhabit in and interact with the 
environment. This is more so when it is interacting with a larger host organism (Tseng et 
al., 2009). This essential process of protein secretion is responsible for pathogenesis and 
symbiosis, the biogenesis of membranes and cell walls, motility, nutrient scavenging and 
uptake. The secreted proteins enter the host cell and modify the host physiology to enable 
bacterial colonization (Holland, 2010). While several specialized secretion systems have 
evolved, especially in Gram-negative bacteria to enable translocation of proteins 
(effectors and toxins) across the double membrane, Gram-positive bacteria seem to utilize 
rather generalized secretion systems to cater to the need for translocation of virulence 
proteins (Papanikou et al., 2007).    
Some bacteria can translocate DNA into the host cell which is later incorporated 
into the host genome thereby altering not only the physiology but also the genetic 
makeup of the host cell. Seven different types of secretion systems have been identified 
so far, six of which are predominant in Gram-negative bacteria and one in Gram-positive 
bacteria. Fig.1.1 summarizes the known secretion systems (Tseng et al., 2009). In Gram-
negative bacteria the proteins are translocated either in a single step or in a two step 
process. Single step translocation involves direct translocation of proteins through the 




the proteins are translocated first into the periplasm via the Sec or Two-arginine (Tat) 
pathways and then translocated across the outer membrane via type II, type V or less  
commonly, the type I or type IV machinery (Tseng et al., 2009). 
 
 
Fig. 1.1. Summary of known bacterial secretion systems. HM: Host membrane; 
OM:outer membrane; IM:inner membrane; MM: mycomembrane; OMP: outer membrane 
protein; MFP: membrane fusion protein. ATPases and chaperones are shown in yellow 
(Tseng et al., 2009).  
 
While in Gram- positive bacteria, the proteins are translocated by a single step via 
Sec or Tat pathways. Mycobacterium despite being Gram-positive has a hydrophobic 
outer cell wall called the mycomemberane. A specialized type VII secretion system helps 
in the translocation of protein across the mycomemberane (Tseng et al., 2009). Sec 
pathway and Tat translocation pathway are simple and more generalized pathways 
present in archaea, prokaryotes and eukaryotes (Tseng et al., 2009). The following 






1.1.1. Sec pathway 
 
The Sec pathway is ubiquitous and essential for viability in all three domains of 
life. In addition, the Sec pathway acts as the entry point for many of the other protein 
export and sorting pathways (Papanikou et al., 2007).  Protein translocation through Sec 
pathway is multi-stage reaction that involves post translational modification. This process 
can be divided into three distinct stages 
a. Protein sorting and targeting. Secretory proteins called the pre-proteins carry 
cleavable amino (N)-terminal signal peptides. These signal peptides act as address 
tags to be sorted from cytoplasmic proteins. They are recognized directly by 
piloting factors, such as the ribonucleoprotein signal-recognition particle (SRP) 
(Luirink and Sinning, 2004) or the SecB chaperone (Randall and Hardy, 2002; 
Schierle et al., 2003). The resulting SRP-pre-protein or SecB-pre-protein 
complexes are targeted to the membrane receptor FtsY and SecA respectively. 
SecA does not contribute to the SRP-translocation; however in case of 
translocation of long, hydrophilic segments SecA is recruited to catalyse the 
export. 
b. Translocation. The translocase consists of membrane embedded protein-
conducting channel built of the SecY, SecE and SecG polypeptides and a 
molecular motor, the SecA ATPase which drives the translocation at the expense 
of metabolic energy or the proton-motive force. 
c. Release and maturation. In this last stage the signal peptides are cleaved off by 
the signal peptidases converting the pre-proteins to mature proteins. The mature 




2006; Mogensen and Otzen, 2005; Nakamoto and Bardwell, 2004). SecYEG 




Fig. 1.2. a. A schematic representation of the bacterial pre-protein translocase 
subunits. The translocase consisits of the Sec YEG pre-protein-conducting channel 
(yellow) and the ATPase motor SecA (red). b. A general schematic representation of 
the secretion process. Secretory pre-proteins (thick orange line) are synthesized with 
amino-terminal signal peptides and are targeted to the translocase either by the ribosome 
–bound signal-recognition particle (SRP) or by the tetrameric SecB chaperone 





SecA ATPase provides the necessary chemo-mechanical energy conversion for 
the translocation (Baud et al., 2002; Karamanou et al., 1999). SecYEG and SecA together 
form the active holoenzyme. SecA binds to SecYEG with higher affinity than to the 
acidic phospholipids. Cytoplasmic exposed loops of SecY are the possible interaction 
sites of SecA. Several auxiliary complexes are also associated to SecYEG translocation 
complexes. 
1.1.2. Tat pathway 
 
The twin-arginine translocation pathway is one of the two general pathways used 
by the bacteria for protein translocation. However, it is unique in that it translocates well 
folded proteins (Palmer and Berks, 2012).  Translocation of well folded proteins is a 
challenging task because they have a much larger cross-section than an unfolded protein 
and so require a larger transport pathway. In addition, they adopt diverse range of shapes 
and sizes, making it difficult to seal tightly around the protein during transport to 
preserve the membrane permeability barrier. Tat pathway is also conserved in plants 
where it is present in the thylakoid membranes and plays a key role in photosynthesis 
(Mori and Cline, 2002).  
The translocation of proteins in Tat pathway is carried out by the integral 
membrane proteins TatA (Settles et al., 1997), TatB (Sargent et al., 1998; Settles et al., 
1997) and TatC (Bogsch et al., 1998). TatA and TatB have a single transmembrane helix 
followed by an amphipathic helix, whereas TatC has multiple transmembrane helices 
(Rollauer et al., 2012; Walther et al., 2010). Proteins to be translocated through the Tat 
pathway are targeted to the system by N-terminal signal peptides possessing a twin-




complex (Frobel et al., 2012). Once the targeted proteins bind to the TatBC complex, Tat 
A is recruited to form a transient TatABC- containing translocation site (Alami et al., 
2003; Mori and Cline, 2002) that facilitates transport by perturbing the membrane bilayer 
(Celedon and Cline, 2013; Palmer and Berks, 2012). TatC is the core organizing 
component of the Tat pathway, directly and dynamically binding substrate, TatB and 
TatA (Fritsch et al., 2012; Frobel et al., 2011), and maintaining interactions during the 
transport step (Gerard and Cline, 2006; Mori and Cline, 2002). TatC is the largest and 
most conserved element of the Tat translocation machinery.  
The presence of an outer membrane in Gram-negative bacteria has forced the 
organism to develop a myriad of specialized secretion systems that would enable them to 
translocate the protein not only across the double membrane but also sometimes into the 
host-cell cytoplasm (Tseng et al., 2009). Some of these secretion systems are 
complemented by the more general secretory pathways like the Sec and the Tat pathways 
(e.g. type II and type V) and others work independent of the general secretory pathways 
(e.g. type I, type III, type IV and type VI pathways).  
Different secretion systems from Gram-negative bacteria are discussed below 
with special emphasis on type III secretion system (T3SS) and type IV secretion system 









1.1.3. Type I Secretion System (T1SS) 
 
Type I secretion is widespread in gram-negative bacteria. The T1SS allows the 
secretion of proteins of various sizes and functions from the cytoplasm to the 
extracellular medium in a single step without a stable periplasmic intermediate (Hueck, 
1998). The proteins targeted to the T1SS have a signal peptide at the carboxy (C) - 
terminus of the protein. The signal peptide is not cleaved during the translocation and 
remains intact with the secreted protein. The signal peptide usually contains distinctive 
glycine rich repeats (GGXGXDXXX) that specifically bind calcium ions forming 
peculiar beta-sandwich or beta-roll structures with calcium ions in the turns. Several 
studies have shown that these repeats are necessary for the activity of the secreted 
proteins (Delepelaire, 2004).  
The translocation machinery is made of three different proteins viz., ATP-binding 
cassette protein (ABC), a membrane fusion protein and an outer membrane protein (C. 
Wandersman, 1996). The ATP-binding cassette protein consists of a NBD (nucleotide-
binding domain of the ABC class with its conserved features) fused to a membrane 
domain (transmembrane domain, TMD) and is localized in the cytoplasmic membrane. 
This recognizes the substrate via its C-terminal secretion signal and is responsible for the 
specificity of the secretion process. Membrane fusion protein (MFP) or adaptor protein 
consists of a short cytoplasmic domain at the N-terminus followed by a membrane anchor 
and a large periplasmic domain. The third member of the system is the outer membrane 
protein (OMP) of the TolC class. The X-ray structure of OMP is shown in the Fig.1.3. 


























Fig. 1.3. Ribbon diagram of the E. coli type I secretion system. OMP TolC from side 
or bottom (i.e. periplasmic entrance) and the ABC protein MsbA from V. cholerae which 
has homologies with ABC components of type I exporters from side and bottom (i.e. 
cytoplasmic side) at the same scale. For both proteins each monomer is colored 
differently and the one with the helices in red displays the beta sheets in pale blue. 
(Delepelaire, 2004) 
 
Type I secretion system translocates unfolded molecules. The identified functions 
of the secreted proteins are quite diverse and a given species can possess up to 16 




for the host, the first one being the HlyA from uropathogenic Escherichia coli and many 
HlyA relatives with different specificities, from bifunctional adenycyclase-hemolysin 
from B. pertussis to the tubulin interacting RtxA toxin from V. cholera. 
1.1.4. Type II Secretion System (T2SS) 
 
T2SS forms a key component of the general secretory pathway (GSP). GSP is a 
two step translocation pathway. The first step involves translocation of the protein across 
the cytoplasmic membrane. The targeted proteins are usually synthesized as pro-proteins 
with a cleavable N-terminal signal peptide. This pro-protein is targeted and transported 
through the inner membrane via Sec pathway (de Keyzer et al., 2003). The signal peptide 
is then cleaved by the leader peptidase releasing the mature protein into the periplasm. 
These set of events constitute the first step and is known as general export pathway 
(GEP). The mature protein is then translocated by machinery, an extension of the GEP, to 
assist its translocation across the OM. These set of events constitute the second step and 
is called the terminal branch of the GSP (Filloux, 2004).  
T2SS is considered the main terminal branch (MTB) of the GSP. T2SS can also 
translocate well folded proteins transported into the periplasmic space by the Tat 
pathway. The periplasmic form might correspond to an extremely short period or may not 
exist, both steps of membrane translocation being then tightly connected. The T2SS is 
broadly conserved in Gram-negative bacteria and involves a set of 12–16 different 
proteins named GspC-M, GspAB, GspN, GspO, and GspS (Filloux, 2004). The type II 
secretion system is highly reminiscent of the type IV piliation assembly. A model of Gsp 
secreton assembly is shown along with a comparison with a model for type IV pilus 




components, protein–protein interactions between Gsps’ and their multimerisation status, 
structural data and electron microscopy observation, a working model has been proposed 













Fig. 1.4. Model of the Gsp secreton assembly (left), and comparison with a model for 
type IV pilus biogenesis in P. aeruginosa (right). On the left, the Gsp dependent 
exoproteins, shown as grey circles, have initially been exported across the IM via the Sec 
or Tat machinery (not shown). The exoproteins are subsequently recognised by the Gsp 
machinery and transported across the OM via the secretin, GspDQ. The secretin GspDQ is 
shown as a homomultimeric ring forming a channel with a large central opening. The 
homologous components of the type IV piliation assembly in P. aeruginosa are shown on 
the right for comparision. The major pilin, PilA, is represented in orange, whereas minor 
pilins (PilE, PilV-X and FimT-U) involved in the type IV pilus assembly but that are not 
found in the extracellular structure are in green. The GspKx homologue, PilX, is 
represented in dark green. Type IV pili are retractile appendages. Retraction is promoted 





T2SS plays a very important role in bacterial pathogenesis. Genes encoding the 
core components of the T2SS are present in many different pathogens. The fact that most 
T2SS dependent enzymes are degradative in nature suggests that the system promotes the 
damage of host cells and tissue, be it plant or animal. Individual exoenzymes have also 
been shown to contribute to virulence. Prominent examples include the ADP-ribosylating 
toxins of enterotoxigenic E. coli (heat labile toxin), V. cholerae (cholera toxin) and P. 
aeruginosa (exotoxin A). T2SS often works in coordination with other secretion systems 
to achieve full virulence; for example T2SS and T4SS are operative in L. pneumophila . 
T2SS and T3SS function in X. campestris (da Silva et al., 2002), and T1SS, T2SS, T3SS 
and T5SS exist in B. pseudomallei and P. aeruginosa (Holden et al., 2004; Stover et al., 
2000). 
1.1.5. Type III Secretion System (T3SS) 
 
T3SS is amongst the bacterial secretion systems that can inject the virulence 
factors or the effector proteins into the host organism. They are present in both 
pathogenic bacteria as well as endosymbionts. The bacteria inject T3S toxins, called 
effectors, through a nano-machine weapon, called injectisome, and involves the assembly 
of a pore in the eukaryotic cell membrane formed by two/three type III secreted proteins 
called ‘translocators’(Mota and Cornelis, 2005). Proteins are thought to travel this 
pathway in a largely unfolded manner, and families of customized cytoplasmic 
chaperones, which specifically bind cognate secreted proteins, are essential for secretion 
(Akeda and Galan, 2005). 
T3SS mainly consists of three groups of proteins: the first group comprises the 




helps in the translocation of proteins is known as translocators and the third group which 
is transported using the T3SS is known as effectors (Coburn et al., 2007). 
The injectisome was originally discovered in Salmonella typhimurium (Kubori et 
al., 1998b), and later identified in several other bacteria. (Blocker et al., 2001; Sekiya et 
al., 2001) (Daniell et al., 2001). It consists of a multi-ring base, which anchors the 
structure to the bacterial envelope, and a needle-like projection that protrudes several 












Fig. 1.5. Needle complex of S. typhimurium. a. Electron micrographs of negatively 
stained isolated needle complexes. b. Cross-section of the structure of the needle complex 
indicating the location of its different substructures. c. Surface rendering of the structure 
of the needle complex. Shown here are different views of the structure of a 20-fold 
complex with 20-fold symmetry imposed (Kubori et al., 1998a).  
 
The base is traversed by cylindrical substructure that connects the needle to the 




channel (~28Å in diameter), which functions as the conduit for proteins traveling through 
this secretion pathway. The opening of the channel that traverses the needle complex is 













Fig. 1.6. Model for substrate recognition and delivery of proteins by type III 
secretion machines. The effector–chaperone complex is recognized by the secretion 
machinery, including a type-III-secretion-associated ATPase. The ATPase ‘strips’ the 
chaperone from the complex, which remains within the bacterial cell, and mediates the 
unfolding and ‘threading’ of the effector protein through the central channel of the needle 
complex. A ‘translocator complex’ made up of proteins also secreted by the T3SS is 
assembled on the host cell membrane and mediates the passage of the effector proteins 
through the target cell membrane. The translocated effectors re-fold within the host cell 
to carry out their function (Collazo and Galán, 1996). 
 
Type III secretion machines translocate a selected number of substrate proteins. 
Some bacteria encode more than one T3SS simultaneously. Therefore, the mechanisms of 




substrates to the appropriate machine. Furthermore, studies indicate that the secretion 
process follows a hierarchy with a predetermined order in which different proteins are 
engaged and secreted by these machines (Collazo and Galán, 1996) (Pettersson et al., 
1996) (Wulff-Strobel et al., 2002). Therefore, it is obvious that the mechanisms of 
substrate recognition are complex, involving multiple signals and accessory proteins 
(Sorg et al., 2005).  
Most proteins targeted by the T3SS posses a secretion signal within the first 20-30 
amino acids (Sory et al., 1995) (Schesser et al., 1996). The signals are not cleaved on 
secretion and do not seem to have any conserved features. Absence of conserved signal 
sequences in the translocated proteins prompts the possibility of some other mechanism 
that ensures specificity. First, it is possible that the unstructured flexible segments at the 
amino terminus serve as a type III secretion signal. Second, accessory proteins such as a 
family of customized cytosolic chaperones that specifically bind at least some of the type 
III secreted proteins (Wattiau and Cornelis, 1993) and help in translocation. 
The type-III-secretion-associated chaperones are small, acidic, dimeric proteins, 
which unlike other chaperones, lack ATP-binding or ATP-hydrolyzing activities 
(Feldman and Cornelis, 2003). The T3SS chaperones do not share significant sequence 
similarity however the structures are related  In general, these chaperones bind a ,50–100 
amino acid domain of the secreted protein, located immediately downstream from the N-
terminal secretion signal. The co-crystal structures of the chaperones and their cognate 
secreted protein showed that these chaperones maintain the chaperone-binding domain of 
their cognate secreted proteins in a non-globular conformation that nevertheless 




the functions of these chaperones must be to ‘prime’ the secreted proteins for rapid 
unfolding before secretion (Stebbins and Galán, 2003). The chaperones also play a key 
role in targeting the secreted protein to the type III secretion apparatus.  
The secretion machine, in addition to recognizing secretion signals on the 
chaperone – effector complex, must ‘strip’ the chaperone from the effector protein 
because T3SS-associated chaperones remain in the bacterial cytosol after delivery of the 
effector proteins to the secretion apparatus. Moreover the limitation in size of the 
secretion channel (estimated to be, 28Å) dictates that the effector domain present at the 
C-terminus of the chaperone binding domain, be unfolded before secretion. Highly 
conserved ATPases associated with the T3SS apparatus play a key role in dissociation of 
the chaperone-effector complex and the unfolding of the effector domain of the effector 
protein (Müller et al., 2006). Furthermore, this unfolding activity may be critical for 
energizing the secretion process.  
The needle complex alone however, is not capable of mediating protein injection 
and needs the activity of a subset of conserved proteins called translocators that are 
themselves secreted by the T3SS (Sory et al., 1995) (Håkansson et al., 1996). This group 
of proteins inserts itself into the target cell membrane forming a channel through which 
the effector proteins can pass on their way to the target cell cytosol (Håkansson et al., 
1996; Sory et al., 1995). A possible scenario is that the needle actually ‘docks’ onto the 
pore or channel made up of the translocators thereby allowing the direct delivery of 
effector proteins into the target cell. One such structures identified in Yersinia 
enterocolitica, is formed by a single protein, LcrV (Mueller et al., 2005). Another more 




plant pathogenic bacteria (Roine et al., 1997). This structure, which is also formed by a 
single protein (for example, EspA in the case of the E.coli T3SS), takes the form of a 
long appendage that extends from the tip of the needle and presumably serves as a 
‘bridge’ linking the needle with the bacterial translocators on the target cell membrane.  
T3SS delivers a unique arsenal of effector proteins, to suit the specific needs of 
the bacteria that harbor them. These proteins delivered by different T3SSs can modulate 
or interfere with a vast array of cellular functions including actin and tubulin dynamics, 
gene expression, vesicular trafficking, programmed cell death and cell cycle progression. 
Most of the effector proteins mimic the host cell proteins and thereby modulate the host 
cellular functions (Fu and Galan, 1999). For example, the Salmonella SPI-1 T3SS 
effector protein SopE is a Rho-family GTPase exchange factor (GEF) that shares no 
sequence or structural similarity with eukaryotic GEFs (Hardt et al., 1998) However, the 
crystal structure of the complex of SopE with its target Rac1 showed that the interaction 
leads to an outcome (that is, conformational changes in the critical switch 1 and switch 2 
regions of Rac1) that is nearly indistinguishable from that of the interaction of a bona fide 
eukaryotic GEF and the same target (Buchwald et al., 2002).. A review of T3SS effectors 









Table 1.1 (continued): T3SS effectors of pathogens for humans  
 
Note: a Some bacteria possess more than one T3S in their genome. The different T3S 
systems are identified for each bacterium by their most common names. SPI (Salmonella 
Pathogenicity Island)-1 and SPI-2 are pathogenicity islands in the Salmonella 
chromosome that encode two distinct T3S systems. b Refs – References. See text for 





Major studies on T3SS were conducted in Yersinia (Cornélis, 1987) Shigella 
(Lindberg and Pál, 1993), Salmonella (Pang et al., 1995), E. coli (Donnenberg et al., 
1993), Pseudomonas and various plant pathogens like Erwinia, Pseudomonas, Ralstonia, 
and Xanthomonas species (Bonas, 1994). A brief description of some of the major 
pathogenic bacteria species with T3SS is given below. 
Salmonella species 
 
Salmonella contain two T3SSs, encoded by two PAIs, namely SPI-1 and SPI-2. 
These two T3SSs play different roles during pathogenesis. SPI-1 is required for initial 
penetration of the intestinal mucosa and SPI-2 is necessary for subsequent stages of 
infection. A broad spectrum of diseases is caused by Salmonella spp. These include 
gastroenteritis, bacteremia, and enteric fever. S. enterica serovar typhi causes typhoid 
fever in humans (Pang et al., 1995). S. enterica and S. enteritidis are major causative 
agents of food poisoning.  
Pathogenic E. coli 
 
E. coli belongs to the family Enterobacteriaceae. Most of the E. coli strains are 
harmless and are found in the intestines of mammals. The harmless strains are part of the 
normal flora of the gut, and can help their hosts by producing vitamin K2, or by 
preventing the establishment of pathogenic bacteria within the intestine. However, certain 
strains like Enterohemorrhagic E. coli (EHEC), Enteropathogenic E. coli (EPEC), 
Enterotoxigenic E. coli (ETEC), Enteroinvasive E. coli (EIEC) and Enteroaggregative E. 
coli (EAEC), are virulent and cause a wide variety of diseases ranging from diarrhea to 







Attaching and Effacing pathogens (AE) pathogens produce shiga toxin 
(verotoxin). Certain serotypes cause enteritis, colitis and diarrhea in humans and a 
number of different animal species by expressing a virulence factor protein called intimin 
which allows intimate attachment of the organism to the microvillus brush border of 
enterocyte forming a characteristic attaching and effacing lesion. AE pathogen infection 
results in the morphological alteration of tight junctions during natural disease. Tight 
junction alteration, characterized by relocalization of the transmembrane tight junction 
proteins results in seepage of molecular tracers. Functional junction disruption occurs 
with a concomitant increase in colon luminal water content (Guttman et al., 2006). 
EHEC, EPEC and Citrobacter rodentium belong to a group of bacterial pathogens known 
as AE. 
Enterohemorrhagic E. coli (EHEC)  
Enterohemorrhagic E. coli (EHEC) is a pathogenic strain of E. coli. EHEC 
belongs to the group of diarrheagenic strains of E. coli that include EPEC, EHEC, ETEC 
and EAEC. It causes hemorrhagic colitis, acute bloody diarrhea and abdominal cramps. 
In children, it can cause hemolytic uremic syndrome, a disease characterized by acute 
renal failure, thrombocytopenia, and micro angiopathic hemolytic anemia (Nataro, 1998 
).  EHEC produces Shiga-like toxin, the key virulence factor responsible for both 
hemorrhagic colitis and hemolytic uremic syndrome. The major genes in EHEC 






Enteropathogenic E. coli (EPEC) 
EHEC, EPEC and mouse pathogen Citrobacter rodentium are the three bacterial 
species that have the locus of enterocyte effacement (LEE). The genes encoding the T3SS 
in all the above species are located in LEE and they are homologous. Moreover, the 
studies on EPEC T3SS can be extended to the other two species also. EPEC and EHEC 
strains are distinguished from other E. coli strains by their ability to inflict characteristic 
lesions in small intestine enterocytes, with gross cytoskeletal damage and loss of brush 














Fig. 1.7. Genes involved in EHEC pathogenesis. Genes involved in EHEC 
pathogenesis are similar to those implicated for EPEC, except for the presence of the Stx 
encoding phage on the EHEC chromosome and the presence of the characteristic EHEC 
60-Mda plasmid instead of the EAF plasmid of EPEC. The EHEC plasmid is known to 
encode the enterohemolysin (ehx) as well as a fimbrial antigen potentially involved in 




After the initial adherence to epithelia, these pathogens attach intimately to the 
epithelial cell surface and cause effacement of microvilli beneath the bacteria, resulting in 
characteristic attaching and effacing (AE) lesions (Moon et al., 1983). In the region of 
contact between bacteria and the epithelial cell surface, cup-like pseudopod structures 
appear which form progressively elongating pedestals carrying individual bacteria on 
their tops (Rosenshine et al., 1996). Intimate attachment, effacing of microvilli and 
formation of pedestals require a bacterial adhesin (called intimin) and EPEC type III 
secretion. Intimin is not secreted by the T3S pathway, but the encoding gene (eaeA) is 
located within the gene cluster that encodes EPEC T3SS (Donnenberg and Kaper, 1991) 
(Jerse et al., 1991) and intimin functions in tandem with type III secretion in pedestal and 
AE lesion formation. Intimin specifically binds to Tir (translocated intimin receptor), 
which is secreted by T3SS and inserted into the eukaryotic membrane (Kenny and Finlay, 
1997). EspA and EspB are the other two T3SS secreted proteins which may be 
translocated into host cytosol (Donnenberg et al., 1993) (Kenny et al., 1996). These 
proteins are required for the membrane insertion of Tir (Kenny and Finlay, 1997). Intimin 
directly binds with Tir, thus showing that EPEC strains transfer their own receptor for 
intimate attachment into eukaryotic cells. Concomitant with pedestal formation, adherent 
EPEC strains induce tyrosine phosphorylation of several proteins in the eukaryotic cell, 
including Hsp90/Tir (Rosenshine et al., 1996; Rosenshine et al., 1992) (Rosenshine et al., 
1992; 1996) and phospholipase C-g1 (Kenny and Finlay, 1997) (Kenny and Finlay, 
1997). The tyrosine phosphorylation and host cell signaling also depend on the type III 




T3SSs are highly regulated to ensure that they function at the appropriate time. In 
their simplest form, the regulatory mechanisms ensure that the secretion machine is 
deployed to the bacterial envelope only when the appropriate cues are present. These 
regulatory mechanisms are largely transcriptional and are specific for each T3SS (Francis 
et al., 2002)  Although the regulatory systems seem specific for each T3SS, a common 
mechanism involves the use of regulatory proteins that themselves are substrates of the 
T3SS. A detailed description of T3SS regulators and regulatory pathways is given in 
Introduction of Chapter II. Previously in our lab, we have determined the structure of 
GrlR (global regulator of LEE, repressor), a negative regulator protein of the LEE operon 
in EHEC (Jobichen et al., 2009; Jobichen et al., 2007). The chapter II of this thesis 
presents the structure of GrlR-GrlA (global regulator of LEE, activator) complex along 
with structure based functional studies. 
Implication of T3SS proteins in therapeutics 
 
Coburn and co-workers (2007) have reviewed T3SS with special emphasis on the 
diseases caused by these proteins and the recent developments in clinical research. 
Fig.1.8 shows the details of pathological importance of T3SS. The T3SS proteins are 
targeted in different ways for controlling the diseases caused by them. Antibodies 
developed against some of the T3SS proteins in Yersinia and Pseudomonas were 
successful in mouse models against septic shock as well as bubonic plague (Apodaca et 
al., 1995; Goure et al., 2005). Studies using T3SS secreted proteins have shown that they 
have the potential to be developed as vaccines for immunizing cattle, the major carriers 
of EHEC pathogens (Potter et al., 2004) (Van Donkersgoed et al., 2005). Possibilities are 




proteins as diagnostic tools (Kauppi et al., 2003; Li et al., 2005). T3SS helps Gram-
negative bacteria to transport a wide variety of proteins (mainly virulence proteins) into 
plant and animal host cells (Hueck, 1998). Recent studies have revealed selected T3SS 
proteins to be potential targets for controlling the diseases that are caused by these 
organisms by specifically attenuating the causative bacterial pathogens without affecting 
the commensal flora. Further developments in this field will eventually aid discovery of 
vaccines and other drugs to specifically inhibit T3SS proteins. 
 
 
Fig. 1.8. T3SS effector functions of path physiologic importance. T3SS effectors have 
been implicated in a variety of critical pathogenic behaviors. These virulence strategies 









1.1.6. Type IV Secretion System (T4SS) 
 
T4SS is a unique bacterial secretion system that can translocate DNA into the host 
organism. Bacteria use T4SS to serve two of its fundamental objectives – genetic 
exchange and delivery of effector molecules to eukaryotic target cells. The T4SSs can be 
classified into three different sub-families  
a. Conjugation family - This is the largest sub-family of the T4SS, and is found in 
most Gram-negative and Gram-positive bacteria. These systems can mediate 
DNA transfer both within and between phylogenitically diverse species, and some 
systems can even deliver DNA to fungi, plants and human cells (eukaryotic cells).  
b. DNA uptake and release family - The second subfamily is the DNA uptake and 
release family, which, function independent of contact with the target cell. This 
subfamily comprises two (DNA uptake) systems — the Campylobacter jejuni  
Cjp/VirB system and the Helicobacter pylori ComB system (Bacon et al., 2000) 
(Hofreuter et al., 1998)- and one DNA-release system, an F-plasmid Tra-like 
system of N.gonorrhoeae.  As with the conjugation machines, these systems 
promote genetic exchange and therefore also represent potential mechanisms for 
the transfer of survival traits during infection (Chen and Dubnau, 2003). 
c. Effector translocator family- This family is indispensable in the infection 
processes of several prominent pathogens of plants and mammals (Fig 1.9). These 
machines can be viewed as ‘injectisomes’, reminiscent of the type III secretion 
(T3S) machines, because they deliver their substrates through direct contact with 

























Fig. 1.9. Schematic representations of the different type-IV-dependent mechanisms. 
The three subfamilies of type IV secretion (T4S) systems are shown. Conjugation 
machines deliver DNA to recipient bacteria and other cell types by cell-to-cell contact. 
DNA-uptake and release systems exchange DNA with the extracellular milieu 
independently of contact with target cells. Effector translocators deliver DNA or protein 
substrates to eukaryotic cells during infection. The effector translocators contribute in 
markedly different way to the infection processes of the bacterial pathogens shown. PT: 




DNA transfer in conjugal systems is enabled by a set of proteins known as the 
DNA transfer and replication (Dtr) proteins. The Dtr proteins act on the origin of transfer 
(oriT) sequence of mobile DNA elements and process the DNA into single-stranded 
DNA and sometimes remains covalently attached to the 5' end of the DNA. One such 
protein, the relaxase, generates a strand-specific nick at oriT and remains covalently 
bound to the 5' end of the T-strand. The translocation competent form of the DNA 
substrate corresponds to a T-strand relaxase nucleoprotein complex (Baron et al., 2002; 
Christie, 1997; Zhu et al., 2000). The DNA and protein substrates recruited to the T4S 
apparatus, are delivered across one or both membranes by the Mpf structure. The 
VirB/D4 system in Agrobacterium is one of the most well studied T4SS. For the A. 
tumefaciens VirB/D4 T4S system, the sub cellular locations and topologies of the VirB 
Mpf proteins have been defined based on computer predictions and a combination of sub 
cellular fractionation and analyses of reporter-protein fusion studies (Fig 1.10). 
The conjugation systems of Gram-negative bacteria are an assembly of three 
distinct substructures: the coupling protein (CP) homomultimer; a transenvelope-protein 
complex; and the conjugative pilus (transfer- or T-pilus). The transenvelope and the 
conjugative pilus are assembled from the mating-pore-formation - for example, VirB1–
VirB11 of the A. tumefaciens VirB/D4 T4S system. The CP, transenvelope complex and 
the T-pilus act in coordination, as a single, supramolecular organelle, to mediate the 
various stages of translocation. These stages include the recruitment of cognate DNA and 
protein substrates to the transfer machine, the transfer of substrates across the cell 







Fig. 1.10. Topologies of the VirB/D4 subunits of the A. tumefaciens T4SS. The 
coupling protein (CP) VirD4 and the mating-pore-formation components (VirB1–
VirB11) are represented according to their proposed functions: energetic (blue), channel 
(red) or pilus (green) components. Several proteins are post-translationally modified in 
the periplasm (Cascales and Christie, 2003; Christie et al., 2005)) 
 
The VirB proteins can be divided into three classes according to known or 
postulated functions (Baron et al., 2002; Christie, 1997)  
i. Channel components which include the inner-membrane proteins VirB6, VirB8 
and VirB10, and the outer-membrane proteins VirB3, VirB7 and VirB9.  
ii. Two ATPases, VirB4 and VirB11, which are localized at the cytoplasmic face of 
the inner membrane, provide energy to drive substrate transfer and, possibly, 




iii. The pilin subunit, VirB2, assembles as the T-pilus in association with VirB5 and 
the VirB7 lipoprotein (Eisenbrandt et al., 1999; Lai and Kado, 2000; Sagulenko 
and Christie, 2001; Schmidt-Eisenlohr et al., 1999).  
The VirB4 and VirB11 ATPases are postulated to either mediate VirB/D4 T4SS 
machine assembly or to function through dynamic, ATP-driven conformational changes. 
Homologues of both ATPases are widely conserved among the T4S system family 
members and VirB11-like ATPases constitute a protein super family that extends to the 
transport machines of many Gram-negative and Gram-positive bacteria and several 
species of the archaea. Conjugation systems have several morphologically distinct pili. 
They can be long and flexible like the F-plasmid pilus (Lawley et al., 2003) or short and 
rigid like the RP4-plasmid pilus (Eisenbrandt et al., 1999). In case of Agrobacterium 
tumifaciens T4SS, the T-pilus resembles the RP4-plasmid pilus and is composed of 
VirB2 pilin. These pili help in substrate transfer by promoting mating-pair formation.  
The T-DNA integration occurs in an illegitimate recombination, a mechanism that 
joins two double-stranded (ds) DNA elements that do not share extensive homology 
(Ziemienowicz, 2001). Till date, it has not been possible to target T-DNA to any 
particular locus in the genome with any great efficiency. However, one of the major 
contributions of A. tumefaciens to genetic engineering research has been the use of T-
DNA as a mutagen to generate the desirable mutant (Valentine, 2003). Moreover, the 
molecular mechanisms of the T-DNA integration remain largely elusive.  It is likely that 
after nuclear import, the ss T-strand is turned into double-stranded DNA (dsDNA) with 




Unlike the transposons and retroviruses, T-DNA itself does not encode enzymes 
that catalyze the integration. Thus, the integration of T-DNA into the plant genome must 
be mediated by proteins imported from A. tumifaciens or by host cell factors. The 
incorporated T-DNA induce plant cells to synthesize opine food substrates and to induce 
proliferation of the transformed plant cells. The outcome of infection is a plant tumor, 
known as a crown gall, which for the bacterium represents a good ecological niche as it 
acts as a food-producing factory. 
T4SS in  A. tumifaciens in addition to the T-DNA also translocates three protein 
effectors, VirE2 (Ward et al., 2002), VirE3 (Schrammeijer, (2003) ) and VirF (Vergunst, 
2000). VirE2 interacts with the T-strand VirD2 particle to form the so-called T-complex, 
VirE3 and VirF participate in largely unspecified ways to promote infection. VirD2 and 
VirE2 carry nuclear-localization sequences (NLS) that enable interactions with plant 
cellular factors and render nuclear targeting, import, and T-DNA integration into the host 
genome. Specific interactions between these two bacterial proteins and several eukaryotic 
factors have been identified. For example, VirD2 binds three members of the Arabidopsis 
cyclophilin chaperone family; these interactions might maintain the proper conformation 
of VirD2 in the host-cell cytoplasm or nucleus during T-complex transit (Deng et al., 
1998). Given the large numbers of cellular factors identified so far, it is likely that the T-
DNA and the reported effector proteins represent only a subset of the molecules 
translocated by the VirB/D4 T4S system during infection. 
Conjugation, competence and other gene-transfer mechanisms help the bacterium 
with the capacity to survive changing environments through the acquisition of adaptive 




render the harsh environment of the eukaryotic host habitable. This is achieved through 

















Fig. 1.11. Schematic representation of the cellular consequences T4SS. T4S effector 
translocation alters various eukaryotic cellular processes, as illustrated for the four 
systems in which effector molecules have been identified so far. Agrobacterium 
tumefaciens delivery of T-DNA and effector proteins induces synthesis of opine food 
substrates and also induces tumour production through modulation of phytohormone 
levels. Helicobacter pylori CagA modulates various pathways associated with 
eukaryotic-cell differentiation, proliferation and motility. Bordetella pertussis 
pertussistoxin (PT) interferes with G-protein-dependent signaling pathways, and 
Legionella pneumophila RalF recruits the ARF (ADP ribosylation factor) family of 
guanosine triphosphatases to the phagosome to promote intracellular survival (Cascales 




Besides A.tumifaciens other pathogens that harbor T4SS for effector translocation 
are mentioned below. 
Bartonella henselae: The causative agent of cat-scratch disease, a relatively benign 
disease that is transmitted to humans by blood-sucking arthropods.  
Bordetella pertussis: Responsible for a respiratory disease known as ‘whooping cough’ 
or pertussis, and transmitted by aerosol droplets. 
Brucella spp: The causative agents of brucellosis, or Malta fever, these organisms are 
transmitted to humans through direct contact with infected animals, carcasses or milk.  
Helicobacter pylori: The causative agent of chronic gastric disorders, and is important in 
the development of peptic ulcer and gastric cancers.  
Legionella pneumophila: Responsible for pneumonia known as ‘legionnaire’s disease’. 
Humans are infected through contact with contaminated water or aerosols. 
Significance of T4SS from A.tumifaciens 
A.tumefaciens-mediated T-DNA transfer to plant is the most popular method for 
the introduction of foreign genes into plant cells and the subsequent regeneration of 
transgenic plants. This method has remarkable advantages over other direct 
transformation methods such as electroporation, microinjection and particle 
bombardment (De la Riva et al., 1998) which include (1) significantly high 
transformation efficiency; (2) easy to manipulate; (3) low copy number of the transgene, 
usually single copy insertion into the plant genome, potentially resulting in fewer 
problems with transgene co-suppression and instability (Hansen et al., 1997); and (4) less 
frequent to form mosaic plants (Enriquez-Obregon et al., 1998). A. tumefaciens 




eukaryotic cells. The molecular mechanism by which it genetically transforms the host 
cells has been the focus of research for a wide spectrum of biologists, from 
bacteriologists to molecular biologists to botanists, for a number of years.  
In addition, A. tumefaciens-mediated T-DNA transfer to plant is the only known 
example of DNA transport between kingdoms that occurs between kingdoms. The T-
DNA is transferred into eukaryotic cells in the form of nucleoprotein complex. The A. 
tumefaciens-mediated T-DNA transfer system can be used as a model system to study the 
molecular mechanism of a wide variety of biological processes such as nucleoprotein 
trafficking, nuclear targeting of nucleoprotein, and the export of virulence effector 
(Christie, 2001). Many of these biological processes are relevant to human pathogen, 
human gene therapy, as well as HIV viral infection.  
1.1.7. Type V Secretion System (T5SS) 
 
T5SSs are known for their simplicity. There are three different types of T5SSs 
viz., the autotransporter system-1 (AT-1 or type Va), the two-partner secretion pathways 
(TPS) (type Vb) pathways and autotransporter system-2 (AT-2 or type Vc) (Fig. 1.12). 
These three systems are characterized by relatively low number of protein components 
involved in the secretion process. They are widely distributed among the pathogenic 
bacteria (Henderson and Nataro, 2001; Henderson et al., 1998; Jacob-Dubuisson et al., 


















Fig. 1.12: Schematic overview of the type V secretion systems. The secretion pathway 
of the autotransporter proteins (type Va) is depicted at the bottom left of the diagram, the 
two-partner system (type Vb) is depicted in the center of the diagram, and the type Vc or 
AT-2 family is depicted on the right. The four functional domains of the proteins are 
shown: the signal sequence, the passenger domain, the linker region, and the β-domain. 
The autotransporter polyproteins are synthesized and generally exported through the 
cytoplasmic membrane via the Sec machinery. (Henderson et al., 2004).  
 
The autotransporter proteins are autonomously secreted across the outer 
membrane, while proteins secreted by TPS systems depend on a specific outer membrane 




represent convergent solutions to the secretion of essentially large proteins with certain 
folding characteristics. 
The proteins targeted by these systems are synthesized with a N-terminal signal 
peptide that help their translocation through the inner membrane by the Sec machinery. 
Effector proteins with an unusual extended signal sequence, mediates SRP-dependent 
export, are found in all three categories of type V secretion (Henderson et al., 1998). 
Once through the inner membrane, the signal sequence is cleaved and the β-domain 
inserts into the outer membrane in a biophysically favored β-barrel structure that forms a 
pore in the outer membrane. AT proteins are modular and in addition to the N-terminal 
signal peptide they have a passenger module which carries out the function of the 
exoprotein followed by a C-terminal translocation module which serves as a conduit for 
the translocation of the passenger domain across the outer membrane (Pugsley, 1993). 
TpsA proteins do not have such transporter domain. They instead have cognate protein 
partners like TpsB that form β-barrel channels in the outer membrane. TpsB helps in the 
translocation of TpsA following a specific recognition event between the two partners 
(Yen et al., 2002) 
1.1.8. Type VI Secretion System (T6SS) 
 
Type VI secretion is widely distributed in Gram-negative bacteria. T6SS is a key 
virulence factor for many pathogenic bacteria and has been implicated in the 
translocation of potential effector proteins into eukaryotic cells eg. Rhizobium 
leguminosarum, V. cholerae, S. enterica, and P. aeruginosa  etc. Studies from our lab 
have shown that this particular system is also present in E. tarda and that they play an 




The components of the T6SS include IcmF homologue, an ATPase ClpV, a 
regulatory forkhead-associated (FHA) protein FHA domain and the secreted proteins 
VgrG and Hcp (Bingle et al., 2008). The T6SS translocation apparatus consists of IcmF-
like and ClpV ATPase proteins. ClpV ATP ases constitute a subfamily of the ClpB 
family, which comprises hexameric enzymes involved in protein quality control. ClpBs 
use ATP energy currency to unfold protein substrates to be degraded. Unlike other 
secretion systems, sequence analysis of T6SS proteins predicts a cytoplasmic location for 
most of the subunits (Cascales, 2008).  Previously from our lab we have reported the 
structure and function of EvpC from E.tarda. EvpC is a close homolog of Hcp1 from 
Pseudomonas aeruginosa. It forms a hexameric ring with a diameter of 40Å that is 
capable of transporting small proteins and ligands (Jobichen et al., 2010). 
The genes that are responsible for T6SS are located in the IAHP (IcmF 
Associated Homologous Protein) cluster. Two genes encode putative inner membrane 
proteins with one (IcmH) or three (IcmF) transmembrane domains. In addition, one 
conserved gene encodes a probable outer membrane lipoprotein. With the exception of 
the R. leguminosarum RbsB protein, the T6S substrates identified so far lack a canonical 
hydrophobic (Sec) or arginine-rich (Tat) N-terminal signal sequence (Cascales, 2008). 
Many pathogenic bacteria known to manipulate host-cell physiologies harbor T6SS. 
T6SS delivers macromolecules that subvert host-cell defenses such as signaling cascades, 
inflammatory responses, intracellular transport, cytoskeleton dynamics or key regulatory 
or metabolic pathways.  Interestingly, Hcp and VgrG are both secreted and part of the 




bacteriophage T4 tail spike, suggesting that the T6S might have evolved from the 













Fig. 1.13. A model for type VI secrection system assembly and function. An inner 
membrane channel formed by the IcmF-like and IcmH-like proteins interacts at the 
cytoplasmic side of the IM with a complex composed of the probable cytosolic type VI 
secrection (T6S) subunits and the ClpV AAA+ ATPase. Recruitment of the ClpV 
multimer is induced by the regulation of forkhead-associated (FHA) phosphorylation 
through the activities of PpkA and PppA, and by the presence of the Hcp protein Putative 
routes for substrate translocation are depicted through the cell envelope and the host-cell 
membrane (blue arrow) including a ‘one-step’ mechanism through a unique channel, and 
a ‘two-step’ mechanism, in which both steps are catalysed by T6S subunits with transient 





1.1.9. Type VII Secretion System (T7SS) 
 
Gram-positive bacteria are enclosed by a simple cell membrane without a cell 
wall. However some Gram-positive bacteria like the mycobacteria have a complex cell 
envelope that contains, in addition to the regular inner membrane, a unique outer 
membrane, also called the mycomembrane, made up of covalently attached mycolic acids 
intercalated with free (glycol) lipids (Hoffmann et al., 2008). Mycobacteria employ the 
most recently discovered transport pathway known as type VII secretion (T7S) for the 
secretion of proteins across this complex cell envelope (Abdallah et al., 2007). The 
presence of the T7SS was initially predicted based on clustering of genes encoding 
secreted proteins that lacked signal sequences with those encoding membrane proteins, 
ATPases and/or chaperones (Tseng et al., 2009). Mycobacterial genomes contain up to 
five T7SS gene clusters (ESX-1 – ESX-5) that do not functionally complement one 
another (Daleke et al., 2012). T7SS gene clusters are also found in the closely related 
pathogens Corynebacterium diphtheriae and Nocardia.  
The structure and functional components of the T7SS are still being pieced 
together. The available studies so far suggest that an integral membrane protein forms the 
translocation channel on the inner membrane and a separate channel in the 
mycomembrane is formed by an as yet unidentified protein (Abdallah et al., 2007) .  
Most of the T7SS substrates contain a unique highly conserved motif, i.e., 
YxxxD/E within the C terminus which is required for translocation. Exchange of these C-
terminal secretion signals between the substrate proteins restored secretion, but each 
substrate protein remained secreted via its own ESX secretion system, indicating that an 






For the present thesis we mainly focus on understanding (1) the regulatory mechanism of 
a T3SS regulatory GrlR-GrlA complex from EHEC and (2) the recruiting mechanism of a 
T4SS recruiting protein: the VirD2 binding protein (VBP) of the VirD4/B T4SS from 
A.tumefaciens 
1.2.1. GrlR-GrlA regulatory complex  
 
GrlA is a positive regulator of the LEE operon and forms a positive regulatory 
loop with Ler. GrlR binds to GrlA and probably inhibits the positive regulatory loop and 
thereby  repressing the expression of LEE operon (Barba et al., 2005). Furthermore GrlA 
negatively regulates flhDC operon (Iyoda et al., 2006) and positively regulates ehxCABD 
operon (Saitoh et al., 2008). We have previously determined the structure of GrlR and 
have speculated that a particular EDED motif of GrlR binds to the highly basic C-
terminal region of GrlA (Jobichen et al., 2007). Our objective for the present study is to 
understand the mechanism by which GrlR-GrlA complex regulates multiple virulence 
operons and enhances pathogenesis in AE pathogens. In particular we want to determine 
the competition between GrlR and Pler in binding to GrlA. Once we establish the 
competition between Pler and GrlR, we would like to verify the same with other 
promoters like the PflhD and Pehx. The following steps are adapted to accomplish our 
objectives: 
1. Determining the structure of GrlR-GrlA complex for understanding the regulatory 
mechanism of the T3SS 
2. Structure based functional studies have to be carried out to reveal the role of the 




3. Characterizing the interactions using biophysical interaction studies  
4. Studying the DNA(Pler) binding property of GrlA 
5. Studying the competition between GrlR and DNA for binding to GrlA 
6. Validation of the results from the aforementioned studies using in vivo EspB 
secretion assay and ler-gfp reporter assay 
7. Extending the DNA binding studies to other promoters like the flhDC (Pflh) and 
ehxCABD (Pehx) 
1.2.2. VirD2 binding protein (VBP) of the VirD4/B T4SS 
 
Recruitment of the VirD2-T-DNA-VirE2 complex (T-complex) is an important 
step in the DNA translocation process of the T4SS (Christie, 1997). VirD2 binding 
protein (VBP) facilitates the recruitment of bulky VirD2-T-DNA-VirE2 complex to the 
VirD4 coupling protein. In addition to VirD2 and VirD4 CP, VBP binds to VirB4 and 
VirB11 ATPases of the T4SS. Besides, VBP plays an important role in bacterial 
conjugation that is independent of T4SS (Guo et al., 2007a; Guo et al., 2007b). 
Understanding the mechanism of recruitment of the T-complex in particular and 
translocation of T-DNA in general, is the main objective of this project. As a first step 
towards understanding this, the structure of VBP and its interaction with its binding 
partner-VirD2 and relevant functional studies have to be carried out. The following steps 
are adapted to accomplish our objectives: 
1. Determining the crystal structure of VBP and/or its individual domains with its 




2. Identifying and studying the functional oligomeric form of the key recruiting 
complex protein VBP 
3. Validation of  the importance of the key amino acids of VBP involved in protein-
protein interactions using structure based functional studies  












































Chapter 2: Structure of GrlR-GrlA Complex that Prevents 

















Attaching and effacing (AE) pathogens are a group of enteric pathogens that 
include the closely related enterohemorrhagic Escherichia coli (EHEC) and 
enteropathogenic E. coli (EPEC). EPEC causes severe diarrhea in young children, while 
EHEC is a causative agent of hemorrhagic colitis and hemolytic uremic syndrome (HUS) 
(Nataro, 1998 ; Pennington.H, 2010). AE pathogens possess type III secretion systems 
(T3SS) that promote virulence. Most components of T3SS and related proteins are 
encoded by genes in the locus of enterocyte effacement (LEE). The LEE consists of 41 
genes, clustered in five different operons termed LEE1-LEE5 and some additional 
transcription units (Deng et al., 2004b). 
Under specific conditions such as low temperature, a histone-like nucleoid-
structuring (H-NS) protein binds to the extended regions within the LEE DNA and 
silences the expression of entire LEE region.  This H-NS-mediated repression, however, 
can be countered by Ler (LEE-encoded regulator), a protein encoded by the first gene in 
the LEE1 operon that functions as a positive regulator of other LEE operons (LEE2-
LEE5) by counteracting this H-NS mediated repression (Barba et al., 2005). Moreover 
Ler is involved in direct or indirect regulation of additional key virulence components of 
EPEC and EHEC and is thus considered as the master regulator of the virulence 
machineries of these pathogens. Accordingly, activation of LEE1 and ler expression is a 
key event in the activation of the entire virulence system of EPEC and EHEC. It is 
therefore not surprising that the LEE1 promoter is subjected to tight regulation by 
multiple factors (Fig. 2.1), including H-NS and Ler, which function as repressor and 




binding of the integration host factor (IHF) protein immediately upstream to the LEE1 
promoter (Barba et al., 2005). Besides, activation of LEE1 expression is promoted by 
proteins belonging to either one of two classes of redundant positive regulators such as 
PerC (Bustamante et al., 2011) (or Pch in EHEC) or GrlA.  
 
Fig. 2.1.  Schematic of the regulatory circuits related to the GrlR-GrlA complex. We 
propose the following model based on results presented in this report as well as results 
previously published by us and other groups. The grlR and grlA genes form a bicistronic 
operon located within the LEE. Under non inducing condition the expression of the entire 
LEE including grlRA is suppressed by H-NS and the activity of the residual GrlA is 
suppressed by GrlR, via direct interaction (repression is indicated by red lines). The 
expression of the entire system can be activated by two alternative modes. The first 




which in turn activate expression of Ler (activation is indicated by blue lines). The 
produced Ler antagonize H-NS and thus stimulate expression of all the other LEE operon 
including grlRA. The produced GrlA directly activate ler expression to establish GrlA-
Ler positive feedback loop. Consequently GrlA further promote, indirectly, the 
expression of all the LEE genes and in addition it directly activates expression of 
the ehxCABD operon and represses the expression of the flagella master 
regulator flhDC. The intensity of GrlA-Ler loop is restrained by autorepression activity of 
Ler and by GrlR, which directly bind GrlA to inhibit its interaction with target DNA. The 
second mode of activation involves environmental signals that trigger the ClpXP protease 
to degrade GrlR and thus releasing GrlA to activate ler expression, leading again to 
establishing of the Ler-GrlA positive loop described above. 
 
The grlR and grlA genes form a transcriptional unit encoding GrlR and GrlA, 
respectively. GrlA is a positive regulator of the LEE1 promoter and thus forms a positive 
regulatory loop with Ler. GrlR binds to GrlA and this is thought to account for the 
negative effect of GrlR on ler expression (Barba et al., 2005; Deng et al., 2004a; Iyoda et 
al., 2006). Since GrlA and GrlR are co-expressed, it is expected that in most cases GrlA 
is inhibited by GrlR and that the relative levels of GrlR and GrlA are regulated. For 
instance, it was  reported that under certain conditions  GrlR is degraded by the ClpXP 
protease, freeing GrlA to activate the Ler expression (Iyoda and Watanabe, 2005). 
 Previously, we reported the structure of GrlR (Fig. 2.2) and elucidated its role in 
LEE regulation (Jobichen et al., 2009; Jobichen et al., 2007). GrlR forms a stable and 
tight dimer in solution as well as in the crystal. The dimeric architecture of GrlR is 
maintained by the cluster of hydrophobic interactions as well as numerous hydrogen 
bonding contacts at the dimeric interface. GrlA has been functionally characterized 




information is available to provide insight into the regulatory mechanisms involving 














Fig. 2.2. Structure of GrlR. Ribbon diagram of the GrlR dimer. Monomer A is shown in 
green, monomer B is shown in cyan (Jobichen et al., 2007). 
 
In addition to its function as a LEE1 regulator, GrlA negatively regulates 
transcription of the flhDC operon and thus controls flagellar gene expression. Kitagawa et 
al (Kitagawa et al., 2011) demonstrated that flagellar gene expression in EHEC is strictly 
regulated by dual pathways, i.e. (i) post-translational control of the FlhDC master 
regulator by protein degradation via ClpXP and (ii) transcriptional control of the flhDC 
operon through the GrlR–GrlA system under conditions in which LEE expression is 
induced. Moreover, it was reported that deletion of grlR resulted in a non motile 
phenotype in the EHEC O157 Sakai strain (Iyoda et al., 2006). In many pathogens, 




induced (Kitagawa et al., 2011). GrlA-dependent repression of flagellar regulation is 
important for efficient adhesion of EHEC to host cells (Iyoda et al., 2006; Kitagawa et 
al., 2011) and perhaps also to avoid detection by the host innate immune sensors TLR5 
and NLRP4 (Deretic, 2012; Fujita and Taguchi, 2012).  
GrlA is also implicated in the transcriptional activation of the ehxCABD operon in 
EHEC (Schmidt et al., 1995; Welch and Pellett, 1988). The ehxA gene encodes 
hemolysin, ehxC acts as a modifying factor that converts the inactive hemolysin into an 
active form by the addition of a fatty acid group (Issartel et al., 1991), and the specific 
secretion machinery required for translocation of EhxA is encoded by ehxB and ehxD 
(Wagner et al., 1983). 
The in vitro instability of GrlA hindered structural studies and attempts to 
elucidate the regulatory mechanism involving Ler, GrlA and GrlR. Here we report the 
crystal structure of GrlAΔ (amino acids (aa) 1-106) in a complex with GrlR refined up to 
2.7 Å resolution. The structure is asymmetric with a stoichiometry of 2GrlR:1GrlA. In 
addition, we identify a novel regulatory mechanism by which GrlR interacts with GrlA at 
its Helix-Turn-Helix (HTH) motif, preventing GrlA from binding to its target promoters 
DNA. 
 
2.2. Materials and Methods 
 
2.2.1. Plasmid and strain construction 
Bacterial strains and plasmids used in this study are listed in Table 2.1.Intact grlR 
and grlA genes were PCR-amplified from EHEC EDL933(Hayward et al., 2006) 




(Novagen; Madison, WI, USA) vector, respectively. Plasmid pET32-grlR was 
constructed by amplifying the grlR gene from EHEC EDL933 chromosomal DNA and 
cloning into pET32 vector. Plasmid pGEX-grlA and pMBP-grlA were constructed by 
amplifying the grlA DNA fragments from EHEC EDL933 chromosomal DNA and 
cloning into pGEX-4T1 (GE Healthcare; Buckinghamshire, UK) and pMAL-c2X (New 
England Biolabs; Ipswich, MA, USA), respectively. The EPEC grlRA null mutant 
(ΔgrlRA::kn) was constructed by replacing the grlRA gene from an EPEC strain with a 
kanamycin cassette by the one-step method using the λ recombinase system(Datsenko 
and Wanner, 2000). Site-specific mutations in grlA and grlR were introduced by 
overlapping PCR (Ho et al., 1989) which uses complementary oligodeoxyribonucleotide 
(oligo) primers and the polymerase chain reaction to generate two DNA fragments having 
overlapping ends. These fragments are annealed, allowing the 3' overlap of each strand to 
serve as a primer for the 3' extension of the complementary strand. The resulting fusion 
product is amplified further by PCR. Specific mutations in the nucleotide sequence were 
introduced by incorporating nucleotide changes into the overlapping oligo primers. Each 
construct was verified by DNA sequencing. To construct pGY1, a DNA fragment 
containing PLEE1 and ler (starting from position -159 compared to the transcriptional start 
site) was amplified using specific primers; this amplified fragment was digested by XbaI 
and BamHI and cloned into pIR1 (Friedberg et al., 1999) digested by the same enzymes. 
The null strain (ΔgrlRA::kn) transformed with pGY1 was named GY2155. 
2.2.2. GrlR-GrlAΔ complex structure determination 
 
pETDuet1-grlR-grlAΔ plasmid was transformed into E. coli BL21 cells and 




37°C until the optical density reached 0.6 at 600 nm. A 1 L culture was induced with 100 
μM IPTG and grown overnight at 20°C. Cells were then harvested by centrifugation and 
resuspended in 40 ml of lysis buffer (50 mM Tris-HCl [pH 7.0], 0.2 M NaCl, 1% (w/v) 
Triton X-100, 5% (w/v) glycerol, 10mM β-mercaptoethanol) with complete protease 
inhibitors (Roche Applied Science; Mannheim, Germany). The GrlA-GrlRΔ complex 
was purified in two steps using Ni-NTA (Qiagen; Valencia, CA, USA), followed by gel 
filtration (Superdex75, GE Healthcare). The 6His tag remained intact on GrlR. Drops 
containing 1 μl of protein solution (7 mg/ml) and 1 μl of reservoir solution were 
equilibrated by hanging drop vapour diffusion at 25°C. The best crystals were grown 
from 12% PEG 3350, 0.1 M sodium malonate pH 5, 0.4 M non-detergent 
sulfobetaines201, with the protein in 30 mM Tris-HCl (pH 7.0), 200 mM NaCl and 5% 
(w/v) glycerol. One complex molecule consisted of two GrlR and one GrlAΔ (2:1) in the 
asymmetric unit, which accounts for a Matthews coefficient of 2.40 Å
3
/Da(Matthews, 
1968), corresponding to a solvent content of 49%. Crystals were cryo protected in the 
reservoir solution supplemented with 25% glycerol and flash cooled at 100K. The 
structure was determined using SeMet-labelled protein crystals by single-wavelength 
anomalous dispersion (SAD)(Terwilliger and Berendzen, 1997a). X-ray diffraction data 
were collected at beamline 13B, National synchrotron radiation research centre (NSRRC, 
Taiwan), using a Quantum-315r CCD area detector (ADSC) and processed with 
HKL2000(Otwinowski and Minor, 1997). All of the expected eight Se sites of an 
asymmetric unit were located using the program Phenix-Autosol. The phases were further 
improved by density modification using RESOLVE(Terwilliger, 2003), which gave a 




built by RESOLVE. The remaining residues were manually built using COOT(Emsley 
and Cowtan, 2004) and refined with phenix-refine(Adams et al., 2010). Refinement was 
continued until the R-value converged to 0.18 (Rfree = 0.23) for reflections I>σ (I) to 2.7 
Å resolution (Table 2.3). The model had good stereochemistry, with 99.3% residues 
falling within the allowed regions of the Ramachandran plot. Subsequently, the 
importance of the key residues in the HTH motif region was validated by structure-based 
in vitro studies, such as isothermal titration calorimetry and pull-down assay. 
2.2.3. Analytical Ultracentrifugation 
 
The stoichiometric ratio of wild-type GrlR-GrlA complex was investigated by 
monitoring their sedimentation properties in sedimentation velocity experiments. 
Samples (400 µl) were used at A280 nm of 1.0 in 30 mM Tris-HCl (pH 7.0), 200 mM 
NaCl, and 5% glycerol. Sedimentation velocity profiles were collected by monitoring the 
absorbance at 280nm. The samples were sedimented at 40,000 rpm at 20°C in a Beckman 
Optima XL-I centrifuge (Beckman Coulter Inc., Brea, CA) fitted with a four-hole AN-60 
rotor and double-sector aluminium centre pieces and equipped with absorbance optics. A 
total of 200 scans were collected and analysed using the Sedfit program(Schuck, 2000). 
2.2.4. Circular dichroism spectrometry 
 
Far UV spectra (260–190 nm) of MBP-GrlA/MBP-GrlAΔ and its substituents 
were measured using a Jasco J-810 spectropolarimeter (Jasco Europe, MI, Italy) in 
phosphate buffer (pH 7.5) at room temperature using a 0.1-cm path length and stoppered 





2.2.5. Isothermal titration calorimetry 
 
MBP-GrlA, MBP-GrlAΔ (with or without substitutions in the HTH motif region) 
and GrlR were all purified in gel filtration buffer containing 30 mM Tris-HCl [pH 7.0], 
200 mM NaCl and 5% glycerol. ITC experiments were carried out using a VP-ITC 
calorimeter (Microcal, LLC; Northampton, MA, USA) at 25°C using 0.01 mM protein 
(MBP-GrlA/MBP-GrlAΔ) in the sample cell and 0.15-0.22 mM GrlR in the injector. All 
samples were thoroughly degassed and then centrifuged to remove precipitates. 
Excluding the first 2-microliter injection, 10-microliter injections were sequentially made 
in each experiment. Consecutive injections were separated by 5 min to allow the peak to 
return to baseline levels. ITC data were analyzed with a model considering a single class 
of binding sites implemented in Origin 7.0 (Origin Lab Corp.; Northampton, MA, USA) 
software. 
2.2.6. Electrophoretic mobility shift assays  
 
EMSAs were performed by mixing approximately 100 ng of DNA (promoter 
region of ler (-275/+217) (numbers indicate the number of base pairs upstream and 
downstream from the functional ATG start codon, respectively), flhDC(-455/+223) or 
ehxCABD(-261/+22) with increasing concentrations of puriﬁed wild-type (WT) or mutant 
MBP-GrlA proteins in binding buffer containing 10 mM Tris-HCl [pH 8], 50 mM KCl, 1 
mM dithiothreitol (DTT), 0.5mM EDTA, 10 µg/ml bovine serum albumin (BSA) and 5% 
glycerol. The primers used to amplify the promoter regions are shown in Table 2.2. 
Reaction mixtures were incubated for 30 min at room temperature and then separated by 
electrophoresis on 5% polyacrylamide gels in 0.5X Tris-borate-EDTA buffer.DNA bands 




(Syngene, Frederick, MD, USA). For competitive EMSAs, DNA was incubated with 
1µM MBP-GrlA for 30 min, followed by the addition of increasing concentrations of 
His-GrlR for an additional 30 min at room temperature. The complexes were visualised 
as described above. The formation of GrlR-GrlA complex in the competitive EMSA was 
verified by setting up a 300µl amylose-resin bound MBP-GrlA–DNA binding reaction 
for 30 min. A 30 µl sample was run as input on EMSA and SDS-PAGE and the rest was 
washed several times with excess DNA binding buffer before titrating with GrlR. A 30 µl 
sample was run after titrating with GrlR followed by washes. The final beads and all 
other washes along with the initial samples were analyzed on both EMSA and SDS-
PAGE gels.  
2.2.7. Extracellular protein extraction and detection 
 
Overnight cultures of EPEC strains were grown in DMEM (Invitrogen; Carlsbad, 
CA, USA) and supplemented with 30 µg/ml of kanamycin, 40 µg/ml streptomycin, 
34µg/ml chloramphenicol until the optical density at 600 nm reached 0.8. The cultures 
were diluted 1:50 into fresh DMEM and incubated for 9 h at 37°C in a shaking water bath 
at 200 rpm. Bacterial cells were removed from the culture by centrifugation (5,500 x g, 
10 min, 4°C), and the supernatant was ﬁltered through a 0.22-µm-pore-size small-protein 
binding ﬁlter (Millex; Millipore). The Extracellular protein (ECP) fraction was isolated 
by trichloroacetic acid precipitation (Shimizu et al., 2002) and the protein pellet was 
washed thrice with -20°C acetone and then air dried. ECP pellets were solubilised in 
Ready Prep reagent 3 (5 M urea, 2 M thiourea, 2% (w/v) CHAPS, 2% (w/v) SB 3–10, 40 
mM Tris, and 0.2% (w/v) Bio-Lyte 3/10 ampholyte (Bio-Rad; Hercules, CA, USA)), and 




membrane. EspB was detected by the addition of diluted anti-EspB (1:2000) polyclonal 
antiserum, followed by a 1:5000 dilution of mouse anti-rabbit IgG HRP (1:5000) (Santa 
Cruz Biotechnology; Santa Cruz, CA, USA). The PVDF membrane was examined using 
the SuperSignal WestPico Chemiluminescent substrate (Pierce Biotechnology; Rockford, 
IL, USA) under the conditions recommended by the manufacturer. 
2.2.8. ler-gfp promoter assay 
 
The plasmid pGY1 contains a transcriptional fusion of the gfp to the ler gene and 
its regulatory region(Yerushalmi et al., 2008). The plasmid was transformed into the 
EPEC grlRA::kn mutant strain EM3715 to create strain GY2155. EPEC strain GY2155 
was then transformed with a compatible, pACYC184-based plasmid, expressing GrlA or 
GrlAΔ and various grlA mutants. The constructed strains were grown in DMEM 
overnight as described above. Cells were then harvested by centrifugation at 5,500 xg for 
10 min at 4°C and re-suspended in lysis buffer (1X PBS) with complete protease 
inhibitors (Roche Applied Science). The cells were lysed and centrifuged down at 
30,000xg for 30 min.Protein concentrations in the supernatant were adjusted and 
separated on an SDS-PAGE, transferred to a PVDF membrane and subjected to western 
blotting. GFP was detected by the addition of diluted anti-GFP (1:2000) rabbit 
monoclonal antibody (Invitrogen), followed by a 1:5000 dilution of mouse anti-rabbit 
IgG HRP (Santa Cruz Biotechnology). The PVDF membrane was examined using the 
SuperSignal WestPico Chemiluminescent substrate under the conditions recommended 





2.2.9. Pull down assay and Western blot 
 
MBP fusions of GrlA protein with or without substitutions in the HTH motif 
region were bound to amylose beads, incubated with His-GrlR overnight, washed and 
eluted with 20 mM maltose. The eluted proteins were separated by 12.5% SDS-PAGE, 
followed by gel staining with coomassie brilliant blue and destained. For western blot 
analysis the proteins were transferred to a PVDF membrane. The membrane was cut 
carefully according to size difference between MBP-GrlA and His GrlR and treated 
separately for detection of the proteins. MBP-GrlA fusion was detected by the addition of 
diluted anti-MBP antiserum (1:2000), (New England Biolabs, UK) followed by a 1:5000 
dilution of mouse anti-rabbit IgG HRP (1:5000) (Santa Cruz Biotechnology; Santa Cruz, 
CA, USA). 6His-GrlR was detected by the addition of anti-His monoclonal antibody 
(1:10000) (Santa Cruz Biotechnology; Santa Cruz, CA, USA). The PVDF membrane was 
examined using the SuperSignal WestPico Chemiluminescent substrate (Pierce 
Biotechnology; Rockford, IL, USA) under the conditions recommended by the 
manufacturer. 
2.2.10. Peptide mass finger printing 
 
Protein bands were excised and washed with 25 mM ammonium bicarbonate 
(ABB) in 50% acetonitrile (ACN) buffer thrice. The proteins in the gel were reduced with 
10 mM DTT in 25 mM ABB buffer, alkylated with 5 mM iodoacetamide, dehydrated and 
digested with trypsin overnight. After in-gel digestion, the solution was transferred to a 
clean tube and sonicated for 30 min in the presence of 50ml 50% ACN and 5% acetic 




pooled extracts were dried with a vacuum concentrator. The samples were processed and 
analysed using a LTQ-FT ultra mass spectrometer. 
For each experiment, MS/MS (dta) spectra were extracted from the raw data ﬁles 
using the extract_msn program in Biowork 3.3 (ThermoFinnigan). The extracted dta ﬁles 
were combined into a single ﬁle in the Mascot generic ﬁle (mgf) format. Except for the 
conversion of precursor mass from MH+ in dta to m/z in mgf, the fragment ion m/z and 
intensity values were used as determined. Proteins were identified by searching the 
combined data against the entire database via an in-house Mascot server (version 2.2.07). 
Two missing cleavages were allowed. Precursor ion and MS/MS fragment ion error 
tolerances were set to < 10 p.p.m. and < 0.8 Da, respectively. A protein was accepted as a 
















Table 2.1: Strains and Plasmids 
Strains or plasmids Description 
EHEC  
EHEC EDL933 EHEC wild type 
EPEC   
E2348/69  EPEC wild type 
3713 E2348/69 grlR::kn 
3714 E2348/69 grlA::kn 
3715 E2348/69 grlRA::kn 
GY2155 EPEC grlRA::kn mutant (strain EM3715) transformed with pGY1plasmid 
E. coli   
BL21(DE3)  (IPTG)* induction of T7 polymerase from  lacUV5 promoter 
Plasmids   
pET-DUET-GrlR-GrlA pET-DUET derivative expressing GrlR with N-terminal His6 tag and GrlA 
without tag 
pET-DUET-GrlR-GrlAΔ pET-DUET-GrlR-GrlA with C-terminal 37 residues of GrlA deleted (aa 1-106) 
pET32-GrlR pET-32 derivative expressing GrlR under the control of the IPTG- inducible 
promoter 
pMBP-GrlA  pMAL-c2X derivative expressing MBP-GrlA under the control of IPTG 
pMBP-GrlAΔ pMAL-c2X derivative expressing MBP-GrlA (aa 1-106) under the control of 
IPTG 
pMBP-GrlA/R53A pMBP-GrlA derivative expressing MBP-GrlA R53A 
pMBP-GrlA/R54A pMBP-GrlA derivative expressing MBP-GrlA R54A 
pMBP-GrlA/R64A pMBP-GrlA derivative expressing MBP-GrlA R64A 
pMBP-GrlA/ R65A pMBP-GrlA derivative expressing MBP-GrlA R65A 
pMBP-GrlA/ K66A pMBP-GrlA derivative expressing MBP-GrlA K66A 
pMBP-GrlA/ Y78A pMBP-GrlA derivative expressing MBP-GrlA Y78A 
pMBP-GrlA/ 5M pMBP-GrlA derivative expressing MBP-GrlA R53A R54A R64A R65A 
K66A  
pMBP-GrlAΔ/ R53A R54A pMAL-c2X derivative expressing MBP-GrlAΔ R53A R54A 
pMBP-GrlAΔ/ R65A K66A  pMAL-c2X derivative expressing MBP-GrlAΔ R65A K66A 
pMBP-GrlAΔ/5M pMAL-c2X derivative expressing MBP-GrlAΔ R53A R54A R64A R65A 
K66A 
pACYC GrlRA pACYC184 derivative expressing GrlR and GrlA 
pACYC GrlRA Δ pACYC184 derivative expressing GrlR and GrlA (aa 1-106) 
pACYC GrlA pACYC184 derivative expressing GrlA  
pACYCGrlA Δ pACYC184 derivative expressing GrlA (aa 1-106) 
pACYC GrlA Δ /R53A pACYCGrlA derivative expressing GrlA (aa 1-106) R53A 
pACYC GrlA Δ /R54A pACYCGrlA derivative expressing GrlA (aa 1-106) R54A 
pACYC GrlA Δ /R64A pACYCGrlA derivative expressing GrlA (aa 1-106) R64A 
pACYC GrlA Δ /R65A pACYCGrlA derivative expressing GrlA (aa 1-106) R65A 
pACYC GrlA Δ /K66A pACYCGrlA derivative expressing GrlA (aa 1-106) K66A 
pACYC GrlA Δ /Y78A pACYCGrlA derivative expressing GrlA (aa 1-106) Y78A 
pACYC GrlA Δ /R65AK66A pACYCGrlA derivative expressing GrlA (aa 1-106) R65AK66A 
pET32-GrlR D17A pET-32 derivative expressing GrlR D17A 
pET32-GrlR S18A pET-32 derivative expressing GrlR S18A 
pET32-GrlR D35A pET-32 derivative expressing GrlR D35A 
pET32-GrlR E60A pET-32 derivative expressing GrlR E60A 
pET32-GrlR N66A pET-32 derivative expressing GrlR N66A 
pGY1 Plasmid containing transcriptional fusion of the ler gene and its regulatory 





Table 2.2: Primers used to amplify the promoter regions 
Primers  
-275 For primer  
ler promoter  
5' CGT TTG TTA ACG AGA TGA TTT TCT TCT ATA TCA TTG ATT TT 3'  
217 Rev primer  
ler promoter 
5' TTC CGG CGA GCG AGT CCA TCA TCA GGC AC 3'  
-261 For primer 
hlyC promoter 
5' CATTTGTCACGTGGCTATTCATATGAAAATCATACGT 3' 
22 Rev primer  
hlyC promoter 
5' CGTCAAAAGCATTAGATTTCATAATGTTTAAATAAATAAGA 3' 
-455 For primer 
flhD promoter 
5' ATG AAA GTG ATT ATT TAT AGC AGA TGA TTA TTT ACG GTG AGT TAT TTT 
AAC TGT GC 3' 
223 Rev primer 
flhD promoter 






2.3.1. GrlR-GrlA/GrlAΔ complex purification, characterization and 
crystallization 
 
GrlR-GrlA/GrlAΔ complex was purified in two stages. The first stage involved 
affinity purification using pre-equilibrated Ni-NTA column followed by a second stage 
size-exclusion chromatography in Superdex75 gel filtration column. The complex eluted 
as a single peak at an elution volume corresponding to a molecular mass of around 47.3 
kDa/ 44kDa. The elution profiles are shown in Fig 2.3 and 2.4. 
 
 
Fig. 2.3. Size-exclusion chromatography profile of GrlR-GrlA complex. The complex 
elutes as a single peak at an elution volume corresponding to a molecular mass of 47 







Fig. 2.4. Size-exclusion chromatography profile of GrlR-GrlAΔ complex. The 
complex elutes as a single peak at an elution volume corresponding to a molecular mass 
of 44 kDa. Molecular weight standard is shown in red. 
 
The molecular mass of 47.5kDa for GrlR-GrlA complex corresponds to two 
molecules of 6His-GrlR and one molecule of GrlA. This GrlR: GrlA stoichiometric ratio 
was further verified by analytical ultracentrifugation (AUC), which showed that the 
complex is of 47.3 kDa, corresponding to two molecules of 6His-GrlR (2*16kDa) and 
one molecule of GrlA (1*15kDa) (Fig. 2.5). The results indicate that GrlA/GrlAΔ form 



















Fig. 2.5. Analytical ultracentrifugation profile of GrlR-GrlA protein complex. AUC 
analysis shows that GrlR-GrlA complex has a molecular weight of 47.3kDa which 
corresponds to two molecules of GrlR and one molecule of GrlA. 
 
Thin plate like crystals appeared as clusters after 18 days at room temperature in 
commercial screen with PEG 3350 based condition (Fig 2.6). Crystallization trials were 








Fig. 2.6. GrlR-GrlAΔ complex crystals from the screen. The crystals shown here 





Grid screening and additive screening were carried out to improve the quality of 
the crystal.  However the crystals were not of good quality. Single, plate like crystals 
were obtained with GrlR-GrlAΔ complex within 3 days in the same condition when 2.0 
M NDSB-201 was added as an additive (Fig 2.6).  
2.3.2. Overall structure of the GrlR-GrlA complex  
 
We initially attempted to determine the structure of full-length GrlA in complex 
with GrlR. However, the full-length GrlR-GrlA complex did not yield diffraction-quality 
crystals, presumably because of the unstable nature of GrlA. As a result, we generated 
GrlR-GrlA complexes with varying lengths of GrlA. A complex of GrlR with GrlAΔ (aa 




Fig. 2.7. Schematic representation of GrlR and GrlA proteins with motifs. 
 
The structure was determined and refined up to 2.7 Å resolution (Fig. 2.8). The 
first 8 residues and last 11 residues of GrlA were not well defined in the electron density 








Fig. 2.8. Crystal structure of GrlR-GrlAΔ complex. The two monomers of GrlR are 
shown in green (monomer A) and cyan (monomer B). GrlA is shown in magenta. The 





Table 2.3: Crystallographic statistics and refinement details 
 
 SelMet SAD 
Data collection  
Space group C2221 
Cell dimensions  
   a, b, c (Å) a = 83.19  b = 121.21   c = 84.83   
 
   α, β, γ () 90 
  
Wavelength 0.97893 
Resolution (Å) 50.0-2.62(2.67-2.62) 
Rsym or Rmerge 0.12 (0.39) 
I / σI 16.23 (3.56) 




Resolution (Å) 15.0-2.7 
No. reflections 22108 
Rwork / Rfree 0.18/0.23 
No. atoms  
    Protein 2543 
    Ligand/ion 26 
    Water 15 
B-factors  
    Protein 53.9 
    Ligand/ion 54.80 
    Water 45.7 
R.m.s deviations  
    Bond lengths (Å) 0.01 
    Bond angles () 1.283 
 
a
 Rsym = |Ii -<I>|/ |Ii| where Ii is the intensity of the i
th
 measurement, and <I> is the mean 
intensity for that reflection. 
 
b
Rwork = | Fobs - Fcalc|/ |Fobs| where Fcalc and Fobs are the calculated and observed 
structure factor amplitudes, respectively. 
 
c
Rfree = as for Rwork, but for 10.0% of the total reflections chosen at random and omitted 
from refinement. 
Individual B-factor refinement was carried out. 





GrlR is a β-barrel protein, structurally similar to our previously determined GrlR 
structures (rmsd of 0.87Å for all Cα atoms) (Jobichen et al., 2009; Jobichen et al., 2007), 
whereas GrlAΔ mainly comprises a Helix-Turn-Helix (HTH) motif (aa 39-66) and an 
anti-parallel β-sheet in the C-terminus (Fig. 2.9 and 2.10). The complex consists of one 
dimer of GrlR bound to a monomer of GrlA (2:1 stoichiometric ratio). There are 15 



































Fig. 2.10. The topology diagram of the GrlA molecule. 
2.3.3. Sequence and structural homology of GrlA   
 
GrlA homologs are present in over 100 species of bacteria including EPEC, 
EHEC, Citrobacter rodentium, Shigella sp. and Salmonella sp. GrlA shares 33% 
sequence identity (46% similarity) with CaiF, a potential transcriptional activator of 
carnitine metabolism in E. coli. GrlA belongs to the PFAM family of DUF1401 
(http://pfam.sanger.ac.uk/family/DUF1401). Despite a very low sequence identity (<7%), 
the DALI (Holm and Sander, 1998) search for structural homologs of GrlA identified 
several regulatory proteins. The closest homologue are also HTH motif containing 
proteins such as a transcriptional regulator from Methanosarcina mazei (PDB 3R0A; 




horikoshii OT3 (PDB 1ULY; RMSD 2.5 Å for 67 Cα atoms) and a double-stranded 
RNA-specific adenosine deaminase (PDB 3F23; RMSD 2.6 Å for 61 Cα atoms). These 
structural similarities suggest that these homologs may have similar functions such as 
transcriptional regulation.  
2.3.4. GrlR interacts with the HTH and C-terminal regions of GrlA 
 
The crystal structure of the complex revealed that GrlR interacts with the HTH 
motif region of GrlAΔ (Fig 2.11, Fig 2.12 and Fig. 2.13). The residues R53, R54, R64, 
R65 and K66 from the HTH region of GrlAΔ are involved in hydrogen bonding contacts 

















Fig. 2.11.  Structure of the GrlR-GrlAΔ interacting surface.  The GrlR dimer is 
shown in surface representation and GrlAΔ is shown as a cartoon. The interacting 



























Fig. 2.13. Structure of the GrlR-GrlAΔ interactions. (a) The interacting residues of 
GrlR (monomer A) in green and GrlAΔ in magenta shown as a stick model. (b) The 





Our previous studies with GrlA (Jobichen et al., 2007) suggested that the C-
terminal region of GrlA might be involved in binding to GrlR. Therefore, we sought to 
independently verify the contribution of the N-terminal HTH motif and the C-terminus of 
GrlA in its interaction with GrlR. To verify this, we created three constructs by 
substituting the above mentioned five interacting amino acids of the HTH motif region 
with alanine (denoted as GrlA5M), truncating the C-terminal region of GrlA (GrlAΔ), or 
both mutations (GrlAΔ5M). Thus, the various GrlA constructs used in these interaction 
studies include MBP-GrlA, MBP-GrlA5M, MBP-GrlAΔ and MBP-GrlAΔ5M. The 
circular dichroism (CD) spectrum of the wild-type and mutants of GrlA suggest that the 
mutants have the same fold as the wild-type GrlA (Fig. 2.14) 
 
Fig. 2.14. Circular dichroism spectroscopic analysis of various MBP-GrlA 
constructs. Readout from Circular Dichroism (CD) spectroscopy analysis showing that 
MBP-GrlA,  MBP-GrlAΔ,  MBP-GrlA5M and MBP-GrlAΔ5M are all well folded and 





The Kd for the interaction between GrlR and MBP-GrlA was determined by 
isothermal titration calorimetry (ITC). GrlR interacts with MBP-GrlA with an 
approximate 35-fold higher affinity (Kd= 0.031 µM) than with MBP-GrlAΔ (Kd=1.1 µM) 
(Fig. 2.15; Table 2.4). Besides the 35- and 31-fold reductions in affinity respectively, 
MBP-GrlA and MBP-GrlA5M also showed thermodynamic profiles distinct from the 
wild-type MBP-GrlA. While the MBP-GrlA interaction with GrlR is enthalpically and 
entropically favourable (H = -4.8 kcal/mol, -TS = -5.4 kcal/mol), the other two protein 
variants (GrlAΔ and GrlA5M) showed an enthalpically driven interaction, with 
unfavorable entropic contributions (H = -21.0 kcal/mol, -TS = 12.9 kcal/mol, for 





















Fig. 2.15. Role of the C-terminal region and the Helix-Turn-Helix (HTH) motif 
region of GrlA in GrlR-GrlA interactions. The binding affinities of MBP-GrlA/MBP-
GrlAΔ to GrlR were determined using isothermal titration calorimetry (ITC). 






Fig. 2.16. Role of the C-terminal region and the Helix-Turn-Helix (HTH) motif 
region of GrlA in GrlR-GrlA interactions (Cont…). The binding affinities of GrlR to 
MBP-GrlA/MBP-GrlAΔ with substitutions in the HTH motif region (5M) were 
determined using ITC. (5M refers to substitutions at R53A R54A R64A R65A K66A.)  
 
Similarly, the Kd for the interaction between GrlR and MBP-GrlA5M was also 
higher (Kd= 0.96 µM) than the wild-type interaction (Fig 2.16; Table 2.4). Probably, the 
C-terminal region in MBP-GrlA, predicted to be mainly unstructured, contributes 
significantly to the desolvation entropy gain associated to the binding, and this 




kcal/mol). Because one of the binding interfaces in MBP-GrlA has been eliminated in 
MBP-GrlA5M, it also shows a smaller desolvation entropy contribution to the overall 
binding entropy (-TS = 6.7 kcal/mol). In addition, because desolvation of protein 
surfaces upon binding is accompanied by a positive unfavorable enthalpic contribution, a 
lower desolvation in the two protein variants will lead to a more favorable enthalpy (H 
= -16.2 kcal/mol for MBP-GrlA; H = -4.8 kcal/mol for MBP- GrlA5M). 
 












MBP-GrlA vs. GrlR 2.13 3.2 · 10
7
 0.031 -10.2 -4.8 -5.4 
MBP-GrlAΔ vs. GrlR 2.05 8.9 · 10
5
 1.1 -8.1 -21.0 12.9 
MBP-GrlA 5M  vs. GrlR 1.03 1.2 · 10
6
 0.96 -8.3 -9.6 1.3 
MBP-GrlAΔ 5M  vs. GrlR No binding 
 
GrlR interacted with the wild-type MBP-GrlA or MBP-GrlAΔ with a 
stoichiometric ratio of 2:1. However, the stoichiometric ratio between GrlR and MBP-
GrlA5M was 1:1, which suggests that two MBP-GrlA5M molecules bind with a dimeric 
GrlR (Table 2.4). The MBP-GrlA5M construct did not show binding to GrlR.  
Subsequently, we examined the role of each of the aforementioned key residues in 
mediating the interaction between GrlR and GrlA by pull-down assay. MBP-GrlAΔ 
containing double amino acid substitutions [MBP-GrlAΔ (R53A R54A), MBP-GrlAΔ 
(R64A R65A) and MBP-GrlAΔ (R65A K66A)] did not interact with GrlR (Fig.2.17a), 















                        
 
 
Fig. 2.17.  Role of the key residues in the Helix-Turn-Helix (HTH) motif region in 
GrlR-GrlAΔ interactions. (a) Pull-down assay to show the binding of GrlA∆ or mutant 
variants with GrlR. MBP-GrlAΔ proteins were bound to amylose beads, incubated with 
6His-GrlR overnight and washed. The eluted proteins were separated by 12.5% SDS-
PAGE, and the gels stained with Coomassie brilliant blue. The GrlA derivatives 
employed are indicated above the lanes: MBP-GrlAΔ (R65A K66A), MBP-GrlAΔ 
(R64A R65A), MBP-GrlAΔ (R53A R54A), wild-type MBP-GrlAΔ and MBP. (b) The 
GrlA derivatives employed are indicated above the lanes: 1.K66A 2.R65A 3.R64A 
4.R54A 5.R53A 6.WT 7.MBP.  
 
Consistent with the ITC results, MBP-GrlA, MBP-GrlAΔ, MBP-GrlA5M pulled 
down GrlR, whereas MBP-GrlAΔ5M did not (Fig. 2.18a). We further verified the role of 
these key residues of GrlR in mediating GrlA binding, showing that alanine substitution 




















Fig. 2.18. Role of the key residues in the Helix-Turn-Helix (HTH) motif region in 
GrlR-GrlAΔ interactions (cont…). (a) Pull-down assay to show the binding of GrlA∆ 
or mutant variants with GrlR. The GrlA derivatives employed are indicated above the 
lanes: 1.MBP 2.MBP-GrlA 3.MBP-GrlA5M 4.MBP-GrlAΔ 5.MBP-GrlAΔ5M. (b) The 
GrlR mutants employed are indicated above the lanes: GrlR D17A, GrlR N66A, GrlR 
S18A, GrlR D35A GrlR E60A and wild-type GrlR. 
 
Moreover, these results were confirmed using a pETDuet-1-grlR-grlAΔ co-
expression and co-purification system with 6His tag on GrlR and a tag less GrlAΔ (Fig. 
2.19). Taken together, these results show that GrlR-GrlA interaction involves both the 






                       a                                                                 b 
Fig. 2.19. Interaction between GrlR and different GrlA constructs. (a and b) The 
pull-down results were reconfirmed in a co-expression, co-purification pETDuet1-grlR-
grlAΔ system (with 6His tag on GrlR and without tag on GrlAΔ) and analyzed on a 
12.5% native gel. The protein derivatives employed are indicated above the lanes. The 
band identities were verified using Peptide mass fingerprint analysis. 
 
2.3.5. ler promoter region and GrlR compete for HTH motif of GrlA 
 
Previous studies demonstrated that GrlA binds to DNA via its HTH motif, and the 
crystal structure of GrlR-GrlAΔ complex revealed that GrlR interacts with the HTH motif 
region of GrlA∆ (Fig. 2.13a,b). Based on these observations, we proposed that promoter 
DNA and GrlR would compete for the HTH motif region of GrlA. To test this prediction, 
we adopted a structure-guided alanine substitution analysis created in the HTH motif 
region of full-length MBP-GrlA at the following positions: R53, R54, R64, R65, and K66 
of the HTH motif and Y78. Electrophoretic mobility shift assays (EMSAs) were 
performed to study the interaction of the GrlA mutants with a DNA fragment containing 












                                                                 
 
 
                             
 
                          
                    
                                                          
 
 
Fig. 2.20. Interaction of GrlA with the ler regulatory region in vitro. (a) 
Electrophoretic mobility shift assays (EMSA) for PCR DNA fragments comprising the 
ler regulatory region (ler-275/+217; numbers indicate the number of base pairs upstream 
and downstream from the functional ATG start codon, respectively) dna VBP is a non-
specific DNA.(b) EMSA with substituted MBP-GrlA proteins. The GrlA species used 
include: wild-type (WT) GrlA, GrlA R53A, GrlA R54A, GrlA R64A, GrlA R65A, GrlA 







Mutants with single alanine substitutions at R53, R54, R65 and K66 exhibited 
mobility shifts that were less than that observed for the wild-type GrlA, indicating a 
reduced affinity for DNA. The MBP-GrlA R64A mutant and a double mutant of MBP-
GrlA (R65A K66A) failed to interact with DNA (Fig. 2.20b, lanes 4 and 8). Furthermore, 
the Y78A mutant formed a shifted complex that was comparable to the wild-type GrlA-
DNA complex (Fig. 2.20b, lane 7). 
To determine whether the addition of GrlR could dissociate MBP-GrlA from the 
ler promoter, a competitive EMSA was conducted (Fig. 2.21). Under the given 
experimental conditions, when the concentration of GrlR was increased to 0.3 µM, the 
MBP-GrlA-DNA complex dissociated. No mobility shift of the DNA was detected at 









Fig. 2.21. Competitive EMSA aimed at testing competition between Pler and 6His-
GrlR for binding to MBP-GrlA. PCR DNA fragments comprising the regulatory region 
(ler-275/+217) were mixed and incubated with 1 µM purified MBP-GrlA for 15 min, 
then combined with increasing concentrations (0.0, 0.15, 0.3, 0.45, and 0.6 µM) of 6His-
GrlR for an additional 15 min. The complexes and free DNA were separated on a 5% 




In order to verify the formation of GrlR-GrlA complex, a pre-formed MBP-GrlA-
DNA complex bound to amylose beads was titrated against GrlR and washed with DNA 
binding buffer. Beads from each of these stages and washes were simultaneously 














Fig. 2.22. Competitive EMSA to study the formation of GrlR-GrlA complex. A 
300µl MBP-GrlA-DNA binding reaction was set up by incubating DNA with amylose-
resin bound MBP-GrlA for 30 min. 30 µl sample was run as input on EMSA and SDS-
PAGE and the rest was washed carefully with excess DNA binding buffer before 
incubating with GrlR. 30 µl sample was run after titrating with GrlR and the rest was 
washed with excess DNA binding buffer. The final beads and all other washes along with 
the initial samples were analyzed on (a) EMSA and (b) SDS-PAGE gels. The final beads 
run in lane 9 show only MBP-GrlA and GrlR on SDS-PAGE and so is marked 
accordingly. EMSA gel showed no apparent shift in the DNA compared to DNA alone 
after the MBP-GrlA-DNA complex was titrated with GrlR (lane 6 and lane 1). SDS-






The EMSA gel analysis showed no apparent shift in the DNA as compared with 
DNA alone after the MBP-GrlA-DNA complex was titrated with GrlR (Fig. 2.22a). SDS-
PAGE showed bands corresponding to MBP-GrlA and GrlR in the final beads (Fig. 
2.22b).These results indicate that DNA bound to MBP-GrlA was replaced by GrlR. 
Besides, these findings show that GrlR outcompetes with DNA to bind to the GrlA HTH 
motif. Next, we sought to verify the ability of DNA to pull out GrlA from the GrlR-GrlA 
complex. A pre-formed GrlA-GrlR complex was incubated with increasing 














Fig. 2.23. EMSA to verify the binding of DNA to preformed GrlR-GrlA complex. A 
preformed MBP-GrlA-GrlR complex was incubated with increasing concentrations of 
DNA for 30 min in DNA binding buffer. The samples were run on 5% EMSA gel and 
stained with ethidium bromide. There is no apparent shift in the DNA incubated with 
preformed MBP-GrlA-GrlR complex compared to DNA alone clearly indicating that 
DNA is not capable of displacing GrlR from the MBP-GrlA-GrlR complex and forming 




There was no apparent shift in the DNA incubated with pre-formed GrlA-GrlR 
complex compared with the control DNA fragment (Fig. 2.23). These results clearly 
show the inability of DNA to displace GrlR from the GrlR-GrlA complex. 
2.3.6. The GrlR-GrlAΔ complex is functional in vivo 
 
We next determined whether the GrlAΔ could form a functional regulatory 
complex with DNA in vivo. To this end, we employed the EPEC null strain (ΔgrlRA::kn), 
which contains a ler-gfp transcriptional fusion (GY2155), and for which the GFP 
expression levels report the activity of the ler promoter. This strain was transformed with 
a plasmid expressing GrlA or GrlAΔ and the GFP levels were compared by western blot 







Fig. 2.24. In vivo functionality of GrlR-GrlAΔ asymmetric complex.  Immunoblot 
analysis using anti-GFP antibodies to compare the expression of GFP via the ler 





); this mutant complemented with plasmids expressing GrlA, GrlAΔ, GrlRA and 
GlRAΔ, as indicted above the lanes. All strains contained a compatible GFP-expressing 
plasmid via the ler promoter. 
 
The results show that the activity of the ler promoter in the strain expressing the 




vivo. This finding also suggests a negligible role of the last 31 amino acids of GrlA in 
terms of ler-promoter binding. The strain expressing both GrlR and GrlA showed less 
activity as compared with the strain expressing GrlA alone, illustrating the repressive 
activity of GrlR. Repression by GrlR in the GrlAΔ-expressing strain was comparable 
with that expressing both GrlR and full-length GrlA (Fig.2.24).  
An additional readout for the functionality of GrlA∆ is the secretion of EspB, 
which reflects Ler expression and functionality (Mellies et al., 1999). EspB is a major 
T3SS effector protein and EspB  secretion acts as an indicator for the formation of a 








Fig. 2.25. In vivo functionality of GrlR-GrlAΔ asymmetric complex (Cont…).  
Secreted proteins were concentrated from supernatants of bacterial culture grown in 
DMEM and resolved using 12% SDS-PAGE. These samples were then transferred to a 
PVDF membrane and analysed using a monoclonal antibody against representative 
secretory protein EspB. The strains used are as in Fig.2.24, but all lack the GFP-
expressing plasmid. Strains are indicated above the lanes as in Fig.2.24. 
 
Our measurements of EspB secretion is in agreement with the data obtained with 
the ler-gfp promoter assay. The secretion assay showed comparable EspB secretion 




full-length GrlA (Fig. 2.25). Similarly, a comparable amount of EspB was secreted from 
the mutant expressing GrlRA or GrlRAΔ. Although deletion of the C-terminal region of 
GrlA resulted in a substantial decrease in the affinity between GrlA and GrlR (Fig. 2.15), 
we did not observe significant phenotypic consequences under the experimental 
conditions used in this study (Fig. 2.24 and Fig 2.25). This suggests that, as long as the 
N-terminal region of GrlA is intact, the protein remains functional. The role of the 
additional interaction from the C-terminal region of GrlA thus remains to be identified. 
2.3.7. The key HTH residues are required for GrlA function in vivo   
 
EspB secretion was further used to examine the role of the key HTH residues in 
the regulatory functions of GrlA. To eliminate the negative regulatory effect of GrlR, we 
transformed the ΔgrlRA::kn null strain with a plasmid expressing GrlA∆. Bacteria were 
grown under conditions that favoured positive regulation of the T3SS by GrlA 
(Bustamante et al., 2011), and the amount of EspB secretion was determined by western 
blot analysis (Fig. 2.26). Secretion of EspB was elevated when the ΔgrlRA::kn null strain 
was supplemented with GrlA∆, and GrlA with alanine substitutions at R65 or K66 
induced efficient EspB secretion (Fig. 2.26). In contrast, the GrlAΔ R64A mutant failed 
to induce EspB secretion (Fig. 2.26) as did the GrlAΔ (R65A K66A) double mutant. 
Taken together, the results show that substitutions in key residues in the GrlA HTH 
region, which hamper binding to the ler regulatory region, elicit a profound effect on the 
ability of the bacteria to assemble a functional T3SS and thus on the bacterial virulence. 
These effects are presumably related to reduced activity of the ler promoter and 





Fig. 2.26. In vivo analysis of the importance of key HTH motif residues in GrlA –
DNA binding. Secreted proteins were concentrated from supernatants of bacterial culture 
grown in DMEM and resolved in 12% SDS-PAGE. The samples were then transferred to 
a PVDF membrane and analysed using polyclonal antiserum against representative 





); this mutant complemented plasmids expressing GrlA or different 
GrlAΔ substitutions, as indicated above the lanes 
 
To more directly test the role of HTH key residues in the activation of the ler 
promoter, we employed the ler-gfp promoter assay described above (Fig. 2.27). The 
EPEC null strain (ΔgrlRA::kn), which contains a ler-gfp transcriptional fusion (GY2155), 
was transformed with a plasmid expressing various grlA mutants. Substitutions such as 
R65A and K66A were well tolerated, unlike R54A and R64A, where the activity of the 
ler promoter was reduced substantially. The results from both the secretion assay and the 
ler-gfp promoter assays were thus consistent, validating the importance of the key 
residues in the HTH motif in mediating the function of GrlA as a positive regulator of ler 






Fig. 2.27. In vivo analysis of the importance of key HTH motif residues in GrlA –
DNA binding (Cont…) Immunoblot analysis using anti-GFP antibodies to compare the 
expression of GFP via the ler promoter. The used strains are similar to those described in 
(Fig. 8a), with the exception that all contain a compatible GFP-expression plasmid via the 
ler promoter. Strains are indicated above the lanes. 
 
2.3.8. GrlR competes with the regulatory regions of flhDC operon for binding 
to GrlA 
 
We next examined whether competition between a promoter region and GrlR for 
binding to GrlA was unique to the ler promoter or a more general mode of operation of 
the GrlR-GrlA system. To this end, we examined two additional GrlA targets: the flhDC 
and ehxCABD promoters. We performed EMSAs by mixing MBP-GrlA with a DNA 
fragment containing the flhDC promoter region (-455/+223). Addition of GrlA shifted the 
DNA, indicating that MBP-GrlA bound to the promoter region of the flhDC operon (-
















Fig. 2.28.  Interaction of MBP-GrlA with the flhDC regulatory region. DNA 
fragment comprising the flhDC regulatory region (flhD -455/223). DNA fragments was 
mixed and incubated with increasing concentrations of purified MBP-GrlA (0, 0.2, 0.4, 
0.6, 0.8, 1, and 1.5 µM). Free DNA and protein-DNA complexes were resolved by 5% 
polyacrylamide gel electrophoresis and stained with ethidium bromide.  
 
Mutants with single alanine substitutions at R53, R54, R65 and K66 exhibited 
mobility shifts that were less than that observed for the wild-type GrlA, indicating a 
reduced affinity for DNA. The MBP-GrlA R64A mutant and a double mutant of MBP-
GrlA (R65A K66A) failed to interact with DNA (Fig. 2.29, lanes 5 and 9). Furthermore, 
the Y78A mutant formed a shifted complex that was comparable to the wild-type GrlA-
DNA complex (Fig. 2.29, lane 8). The results indicate that the binding behavior of MBP-
GrlA mutants to the flhDC regulatory region is similar to the binding of MBP-GrlA 


















Fig. 2.29. Interaction of MBP-GrlA mutants with the flhDC regulatory region. DNA 
fragment comprising the flhDC regulatory region (flhD -455/223). DNA fragments was 
mixed and incubated with increasing concentrations of purified MBP-GrlA.  Free DNA 
and protein-DNA complexes were resolved by 5% polyacrylamide gel electrophoresis 
and stained with ethidium bromide. The GrlA species used include: wild-type (WT) 
GrlA, GrlA R53A, GrlA R54A, GrlA R64A, GrlA R65A, GrlA K66A, GrlA Y78A, 
GrlAR65AK66A, and ler pr (ler -275/217). 
 
To determine whether the addition of GrlR could dissociate MBP-GrlA from the 
flhD promoter, a competitive EMSA was conducted (Fig. 2.30). Under the given 
experimental conditions, when the concentration of GrlR was increased to 0.8µM, the 
MBP-GrlA-DNA complex dissociated. No mobility shift of the DNA was detected at 
















Fig. 2.30. Competitive EMSA carried out to test the competition between flhDC 
regulatory region and 6HisGrlR for binding to MBP-GrlA. PCR DNA fragments 
comprising the regulatory region (flhD -455/+223) were mixed and incubated with 
purified MBP-GrlA 1 µM for 15 min, then increasing concentrations (0 0.2 0.4 0.6 0.8 
1.0) µM of HisGrlR were added and incubated for additional 15 min. The complexes and 
free DNA were run in 5% polyacrylamide gel and stained with ethidium bromide. flhD 
pr: (flhD -455/+223).   
 
2.3.9. GrlR competes with the regulatory regions of ehxCABD operon for 
binding to GrlA 
 
We next investigated a direct role of the GrlR-GrlA system in controlling the 
ehxCABD operon by EMSA assays. MBP-GrlA bound to the ehx promoter region (-
261/22). Subsequent EMSA experiments using mutant MBP-GrlA showed various 
degrees of reduction in the mobility shifts, consistent with those seen for GrlA binding to 
ler and the flhDC promoter regions. Cumulatively, our findings suggest that the general 
mode of operation of the GrlR-GrlA system involves mutually exclusive binding of the 












Fig. 2.31. Interaction of GrlA with the ehxCABD regulatory region. DNA fragment 
comprising the ehxC regulatory region (-261/22). DNA fragments was mixed and 
incubated with increasing concentrations of purified MBP-GrlA (0, 0.2, 0.4, 0.6, 0.8, 1, 
and 1.2 µM). Free DNA and protein-DNA complexes were resolved by 5% 
polyacrylamide gel electrophoresis and stained with ethidium bromide. 
 
 
Fig. 2.32. EMSA with ehxCABD regulatory region and mutant MBP-GrlA proteins. 
The used GrlA species include: wild type GrlA (WT), GrlA R53A, GrlA R54A, GrlA 














Fig. 2.33. Competitive EMSA carried out to test the competition between ehxCABD 
regulatory region and 6HisGrlR for binding to MBP-GrlA. PCR DNA fragments 
comprising the regulatory region (ehxC (-261/22)) were mixed and incubated with 
purified MBP-GrlA 1 µM for 15 min, then increasing concentrations (0 0.2 0.4 0.6 0.8 
1.0) µM of HisGrlR were added and incubated for additional 15 min. The complexes and 
free DNA were run in 5% polyacrylamide gel and stained with ethidium bromide. ehxc 




Extensive functional analyses have shown that the GrlR-GrlA is a key regulatory 
complex involved in the direct or indirect regulation of most virulence genes in AE 
pathogens, including EPEC, EHEC and C. rodentium (Barba et al., 2005; Deng et al., 
2004a; Iyoda et al., 2006). These studies include demonstration of the regulatory role of 
the GrlR-GrlA system in three independent operons: LEE1, flhDC and ehxCABD (Barba 
et al., 2005; Kitagawa et al., 2011; Saitoh et al., 2008). GrlA positively regulates the 
expression of ler, the first gene in the LEE1 operon, which in turn regulates the 




2005). In addition to LEE1, GrlA is also involved in the positive regulation of ehxCABD 
operons and the negative regulation of the flhDC operon (Fig. 2.1). GrlR binds directly to 
GrlA and functions as an anti-regulator (Barba et al., 2005). However, the molecular 
details of the regulation of the GrlR-GrlA complex have, until now, remained elusive 
because of the lack of structural details. Here, we close this gap, reporting the crystal 
structure of the GrlR-GrlAΔ complex, along with supportive functional studies. 
In a previous study, we reported the binding between GrlR and GrlA mediated by 




 motif of GrlR with the C-terminal region of GrlA 
(Jobichen et al., 2007). However, we could not confirm this finding in the present 
complex structure because of the absence of the C-terminal region (aa107-137) of GrlA 
in the crystallized construct, wherein a majority of GrlAΔ interactions occur with one 
monomer of the dimeric GrlR. Despite this, we were able to verify the binding of full-
length GrlA to GrlR using ITC and pull down experiments (Fig.15; Fig.18a; Table.2.4). 
The ITC experiments indicated that full-length GrlA binds to GrlR with a ~35-fold higher 
affinity than GrlAΔ. These results suggest the role of the GrlA C-terminus in its 
interaction with GrlR. Despite this difference in affinity, under the employed 
experimental conditions, GrlAΔ exhibited an activity comparable to full-length GrlA 
(Fig. 2.24 and Fig 2.25).  
 Previous studies of the GrlR-GrlA interaction were performed with GST-tagged 
proteins (Jiménez et al., 2010; Jobichen et al., 2007). These studies suggest that the GST 
tag might interfere with the interaction, and could be the reason for the complete 








pitfall, the current experiments were carried out using MBP-tagged GrlA. We and others 
have independently verified that MBP is not involved in the GrlA-GrlR interaction 
(Jiménez et al., 2010).  
Here, we show that substitutions in the HTH motif of GrlA∆ interfered with GrlR 
binding, while the full-length GrlA with substitutions in the HTH region was able to bind 
to GrlR probably through its C-terminal region (Fig. 16; Fig. 18a; Table 2.4).Jimenez et 
al. show that GrlA∆1(aa1-100) was able to pull down GrlR (Jiménez et al., 2010), and our 
observation of two binding sites agrees with this finding. Thus, even though the binding 
site located to the GrlA C-terminus was deleted; these deletion constructs can still pull 
down GrlR via this alternative binding site located at the HTH region.  
Our data shows that GrlR interacts with GrlA to prevent its binding to target 
DNA. The fact that grlR and grlA are co-transcribed raises the question of under what 
conditions GrlA can escape suppression by GrlR and interact with its target DNA. Given 
the tight GrlR-GrlA mode of interaction and the observation that two GrlR molecules are 
needed to suppress one GrlA molecule, it can be assumed that GrlA will function as a 
regulator only when its steady state level reaches more than half of that for GrlR. The 
relative steady state level of the two proteins is controlled by their relative translation 
rates and stability. While virtually nothing is known about the first, it is expected that the 
translation rate would be equal in generating both GrlR-bound, as well as free, GrlA.  The 
differential stability and specific GrlR degradation by ClpXP has been previously 
reported (Iyoda et al., 2006). An additional point of view on this system is that GrlR in 




functional and rapidly released following an appropriate signal and ClpXP-mediated 
GrlR degradation. 
In conclusion, the present study revealed the molecular structure and mechanism 
of the GrlR-GrlA complex. GrlR and the promoter regions of ler, flhDC and ehxCABD 
compete for the HTH motif region of GrlA. GrlR outcompetes with these promoter DNA 
sequences for GrlA. Regulation of multiple virulence operons by a central hetero-trimeric 
GrlR-GrlA complex would help the pathogen to precisely control the expression of 
various genes involved in its pathogenesis. By differentially regulating the ler and ehx 
operons positively and the flhDC operon negatively, GrlR and GrlA coordinate and 
optimize gene expression by the pathogen during the infection process. 
The next chapter discusses the structural and functional characterization of VirD2 


























Chapter 3: Dimerization of VirD2 Binding Protein from the 
Type IV Secretion System is essential for Agrobacterium 












3.1. Introduction  
 
The Type IV Secretion System (T4SS) has an unmatched versatility among the 
seven different secretion systems known in bacteria. T4SS can translocate not only 
proteins but also DNA to phylogenitically diverse taxa, including many bacterial species 
and different types of eukaryotic cells, as well as import and export DNA from the 
extracellular milieu. The T4SS  shares a common ancestry with bacterial conjugation 
systems (Cascales and Christie, 2003). Three types of T4SS have been described: (1) 
conjugation systems, defined as machines that translocate DNA substrates to recipient 
cells by a contact-dependent process; (2) effector translocation systems, functioning to 
deliver proteins or other effector molecules to eukaryotic target cells; (3) DNA release or 
uptake systems that translocate DNA to or from the extracellular milieu  (Alvarez-
Martinez and Christie, 2009). 
 Conjugation, similar to other gene transfer mechanisms, endows bacterium 
with the capacity to survive changing environments through the acquisition of adaptive 
traits. The proteins involved in these conjugation systems are classified into three 
functionally distinct classes (Christie et al., 2005). For the VirB/D4 (virulence B/D4) 
conjugation system of Agrobacterium tumefaciens, Class I constitutes proteins involved 
in the processing and packing of transferred DNA intermediates (VirD2 relaxase, VirD1, 
VirC proteins, VirE2, VirE1 and VirF) (Tzfira and Citovsky, 2000). Class II comprises 
11 VirB proteins that form the T4SS apparatus, which functions to translocate the VirD2-
T-DNA-VirE2 complex (T-DNA-protein complex) into plant cells (Tzfira and Citovsky, 
2000). Class III constitutes the coupling proteins (CP) that mediate the interaction 




1997). In the A. tumefaciens VirB/D4 system, the coupling protein is VirD4, an inner 
membrane protein with a large cytoplasmic domain that is required for the transfer of 
both T-strand and VirE2 to host cells (Hamilton et al., 2000; Kumar and Das, 2002; 
Okamoto et al., 1991).  
The T-DNA-protein complex forms in the cytoplasm, but there is no evidence to 
suggest that VirD4 CP can recruit the bulky T-DNA-protein complex to the T4SS 
apparatus (Guo et al., 2007a). In 2007, Guo et al. reported the existence of a subset of 
proteins defined as ‘recruiting proteins’ that help recruit the nucleoprotein substrate 
complex to the VirD4 CP. The VirD2 binding protein (VBP) was identified as a key 
protein belonging to this subset and was shown to recruit the T-DNA-protein complex to 
the VirD4 CP (Guo et al., 2007b). Site-directed mutagenesis has shown that the VBP-
VirD2 interaction is important for T-DNA transfer (Guo et al., 2007b), with VBP 
interacting with both the T-DNA-protein complex and independently with several T4SS 
components, including VirD4, VirB4 and VirB11. However, the molecular mechanism(s) 
by which VBP recruits the complex to VirD4 coupling protein remains unknown.  
Here we report the crystal structure of the C-terminal domain of VBP along with 
its functional studies. The two monomers of the asymmetric unit form a tight anti-parallel 
dimer and structural analysis confirms that this domain adopts a HEPN (higher 
eukaryotes and prokaryotes nucleotide-binding) fold. Solution studies with gel filtration 
and analytical ultracentrifugation confirm the dimeric nature of HEPN and full-length 
VBP. Furthermore, the HEPN domain is revealed as the dimerization domain of VBP. 




inducing tumors in plants. These studies broaden the understanding the role of VBP in 
the T-DNA-protein transfer from A. tumefaciens to the plant cell. 
 
3.2. Materials and Methods 
 
3.2.1. Plasmid and strain construction 
 
The strains and plasmids used are given in Table S3. Intact vbp and vird2 genes 
were amplified from A. tumefaciens C58 plasmid and Ti plasmid, respectively. These 
genes were then cloned to pET32a (Novagen; Madison, WI, USA) and pRSET 
(Invitrogen, Carlsbad, CA, USA) vectors, respectively. N-terminal nucleotidyltransferase 
(NT) domain and C-terminal HEPN domain vbp constructs were created using specific 
primers that amplify these regions and were cloned into pGEX-6p1 (GE Healthcare; 
Buckinghamshire, UK). Site-specific mutations in vbp were introduced by overlapping 
PCR, as described previously (Ho et al., 1989). Each construct was verified by DNA 
sequencing. A fragment of virF cassette cloned from pTiBo542 (GenBank: DQ058764.1) 
was inserted into the SphI–ApaI site on pCB301 (Oliver et al., 1999). The virF coding 
sequence was substituted with a multiple cloning site, resulting in pQH300. 
3.2.2. Protein expression and purification 
 
The plasmid pET32a-vbp was transformed into E. coli BL21 (DE3) cells and was 
grown in LB broth at 37°C overnight. The overnight culture was transferred into 1 L of 
LB broth and the protein expression was induced at an absorbance of 0.6 with 350 μM 
IPTG for 20 h at 20°C. Cells were harvested and lysed in lysis buffer (20 mM Tris-HCl, 




supernatants transferred to affinity columns containing Ni-NTA agarose (Qiagen; 
Valencia, CA, USA), pre-equilibrated with the lysis buffer. The His6-VBP bound to Ni-
NTA was eluted with 400 mM imidazole following three wash steps to remove non-
specific proteins. The eluted protein was purified through size-exclusion chromatography 
using a HiLoad 16/12075 Superdex75 gel filtration column (AKTA FPLC UPC-900 
system, GE Healthcare) containing buffer (20 mM Tris-HCl, pH 8.0, 200 mM NaCl, and 
5% glycerol). The GST fusion proteins (GST-HEPN and GST-NTD) were expressed as 
described above using M9 media (Doublié, 1997). The fusion proteins were purified by 
affinity chromatography on GST-Sepharose resin, and the tags were removed by cleavage 
with precession proteases (GE Healthcare; Buckinghamshire, UK). The HEPN domain 
was additionally purified by size-exclusion chromatography in gel-filtration buffer (30 
mM CHES pH 9.0, NaCl 200 mM, 5% glycerol). The NT domain was purified in the 
same way but using a buffer containing 30 mM Tris-HCl, pH 7.5 and 200 mM NaCl 
buffer. 
3.2.3. Crystallization and data collection  
 
Initial crystallization conditions were identified by hanging drop vapor diffusion 
method using an index screen (Hampton Research, Aliso Viejo, CA, USA). Diffraction-
quality crystals were obtained by equilibrating a l.0 µl drop of protein (4 mg/ml) in 30 
mM CHES, pH 9.0, 200 mM NaCl and 5% glycerol mixed with 1.0 µl of reservoir 
solution (8% (w/v) PEG 3350, 2% v/v tacsimate, 5% v/v 2-proponal, and 0.1 M 
imidazole) suspended over 1 ml of reservoir solution. Crystals grew in 1–3 days at 16°C. 
For data collection, 15% glycerol was added as a cryo-protectant and the crystals were 




A complete single wavelength anomalous diffraction (SAD) (Terwilliger and 
Berendzen, 1997b) dataset was collected to 2.7 Å resolution at the synchrotron beamline 
X6A (National Synchrotron Light Source, Brookhaven National Laboratory, Upton, NY) 
using a Quantum4-CCD detector (Area Detector Systems Corp., Poway, CA). The 
datasets were processed and scaled using HKL2000 (Otwinowski and Minor, 1997). The 
crystals belonged to a P212121 space group. There were two monomers in the asymmetric 




 and a solvent content of 50.6%. The position of 
the selenium atoms were determined using the program Phenix Autosol (Terwilliger, 
2003). The obtained phases were further improved by density modification using 
RESOLVE (Terwilliger, 2003). Over 50% of the backbone atoms of the model were built 
by RESOLVE. The remaining residues were manually built using Coot (Emsley and 
Cowtan, 2004) and subsequently  refined using Phenix-refine (Adams et al., 2010). 
Refinement was continued until the R-value converged to 0.22 (Rfree = 0.27) for 
reflections I>σ (I) to 2.7 Å resolution (Table 1). The model had good stereochemistry, 
with 99.3% residues within the allowed regions of the Ramachandran plot. Subsequently, 
the importance of the key residues at the dimeric interface was validated by structure-
based in vitro studies, such as analytical ultracentrifugation and pull down assays, and in 
vivo plant virulence studies.  
3.2.4. Analytical Ultracentrifugation  
 
The oligomeric state of full-length VBP, HEPN and NTD domain of VBP and 
their mutants was investigated by monitoring the sedimentation properties of each protein 
in sedimentation velocity experiments. For these experiments, 400 μl of samples at 1 




sedimentation velocity profiles were collected by monitoring the absorbance at 280 nm. 
The samples were centrifuged at 40,000 rpm at 24°C in a Beckman Optima XL-I 
centrifuge fitted with a four-hole AN-60 rotor and double-sector aluminum centerpieces 
and equipped with absorbance optics. 80 scans were collected and analyzed using Sedfit 
program (Brown and Schuck, 2006). 
3.2.5. Pull down assay 
 
MBP-VirD2 bound to amylose resin (New England Biolabs, Ipswich, MA, USA) 
was incubated with purified 6His-VBP, with or without substitution at Asn186Asp. The 
beads were washed several times before resolving the eluent on 12.5% SDS-PAGE. For 
western blot analysis, the proteins were transferred to a PVDF membrane. 6His-VBP was 
detected by the addition of diluted anti-His antibody (Santa Cruz Biotechnology; Santa 
Cruz, CA, USA). The signal was detected using the SuperSignal WestPico 
Chemiluminescent substrate (Pierce Biotechnology; Rockford, IL, USA) under the 
conditions recommended by the manufacturer. 
3.2.6. Isothermal titration calorimetry 
 
His-VBP, with or without substitution at Asn186Asp, were purified in gel 
filtration buffer containing 30 mM Tris-HCl, pH 8.0, 200 mM NaCl and 5% glycerol. 
ITC experiments were carried out using a VP-ITC calorimeter (Microcal, LLC, 
Northampton, MA, USA) at 25°C using 0.01 mM VBP protein in the sample cell and 
0.25 mM AMP-PNP in the injector. All samples were thoroughly degassed and then 
centrifuged to remove precipitates. With the exception of the first experiment, 10 μl 
volumes per injection were used for different experiments. Consecutive injections were 




with a single-site fitting model using Origin 7.0 (Origin Lab Corp., Northampton, MA, 
USA) software. 
3.2.7. Circular dichroism spectrometry  
 
Far UV spectra (260–190 nm) of VBP, HEPN, NTD domains and their mutants 
were measured using a Jasco J-810 spectropolarimeter (Jasco Europe, MI, Italy) in 
phosphate buffer (pH 7.5) at room temperature using a 0.1-cm path length-stoppered 
cuvette. Six scans were recorded, averaged and then baseline subtracted to obtain values. 
3.2.8. Plant virulence Assay 
 
A. tumefaciens strains were grown in MG/L liquid medium overnight at 28°C 
supplemented with appropriate antibiotics. The bacterial cells were collected by 
centrifugation and re-suspended in a buffer solution consisting of 10 mM MgCl2 and 10 
mM MES, pH5.5. Cell concentrations were adjusted to OD600 = 0.1. The leaves 
of Kalanchoe were wounded with a hypodermic syringe needle and 5 μl of bacterial cell 
suspension was inoculated onto each wound area. The tumors were photographed 25 and 



















3.3.1. Overall structure  
 
We initially attempted to crystallize full-length VBP with intact N- and C-
terminal domains (Fig. 3.1).  
 
Fig. 3.1. Schematic representation of VBP and its domains. Based on the sequences 
analysis, the N-terminal (aa 10-133) is predicted to be a Nucleotidyltransferase (NT) 
domain and the C-terminal domain is predicted to be Higher Eukaryotes and Prokaryotes 
Nucleotide (HEPN) (aa 159-279) binding domain.  
 
Peptide-mass finger printing analysis on the crystals showed that only the C-
terminal domain of VBP had crystallized. The boundaries of the crystallized protein were 
determined using N-terminal sequencing and mass spectrometric analysis. Subsequently, 
we generated a new construct that consisted of the C-terminal domain, and obtained 
crystals that diffracted up to 2.7 Å resolution.  The structure was determined using the 
SAD method. The asymmetric unit consists of two monomers forming a tight dimer. 
Each monomer contains a five-helix bundle with three long anti-parallel α helices (α1, 
α2, and α6) that forms the major part of this domain, and three shorter helices (α3, α4 and 
α5) that stack at an angle to the long helices (Fig. 3.2 and Table 3.1). The monomers are 
arranged as anti-parallel dimers with a large buried surface area of 2255.6 Å
2 
(or 13% of 
the total surface area of each monomer). The dimer is held together by tight interactions 






Fig. 3.2. Structure of the HEPN domain of VBP. The asymmetric unit contains two 
monomers that form a tight dimer. Chain A is shown in light orange and Chain B is 







Table  3.1: Crystallographic statistics and refinement details 
 
 SelMet SAD 
Data collection  
Space group P212121 
Cell dimensions  
a, b, c (Å) a = 63.10  b = 71.57   c = 83.42   
 
α, β, γ () 90 
  
Wavelength 0.97945 
Resolution (Å) 50.0-2.7(2.75-2.7) 
Rsym or Rmerge 0.05 (0.15) 
I / σI 22.4 (5.5) 
Completeness (%) 99.7(99.3) 
Redundancy 7.5 (7.4) 
  
Refinement  
Resolution (Å) 14.8-2.7 
No. reflections 10677 
Rwork / Rfree 0.22/0.27 
No. atoms   
    Protein 2248 
    Water 13 
B-factors  
    Protein 63 
    Water 57 
R.m.s deviations  
    Bond lengths (Å) 0.04 
    Bond angles () 0.897 
 
a
 Rsym = |Ii -<I>|/ |Ii| where Ii is the intensity of the i
th
 measurement, and <I> is the mean 
intensity for that reflection. 
 
b
Rwork = | Fobs - Fcalc|/ |Fobs| where Fcalc and Fobs are the calculated and observed 
structure factor amplitudes, respectively. 
c
Rfree = as for Rwork, but for 10.0% of the total reflections chosen at random and omitted 
from refinement. 
Individual B-factor refinement was carried out. 










































3.3.2. Sequence and structural homology  
 
 PSI–BLAST searches of the non-redundant protein database using the full length 
VBP (gi|159141484) resulted in several hits of nucleotidyl transferase proteins from 
Rhizobium, Sinorhizobium and other species of Agrobacterium. Sequence based 
predictions revealed that VBP has two domains such as an NT_KNTase_like domain at 
the N-terminus and a HEPN domain at the C-terminus. The NT domain is implicated in 
nucleotidyl transfersae function while HEPN domain is implicated in nucleotide binding 
(Altschul et al., 1997).  A DALI search for the structural homologs of VBP C-terminal 
domain identified several proteins with a HEPN domain (Table 3.2); this confirmed that 
the C-terminal domain of VBP adopts a HEPN fold (hereafter referred to as HEPN 
domain). 
Table 3.2:  Structural homologs of HEPN domain as predicted by DALI search 
No PDB z rmsd aa  Total 
residues 
%id Protein name/detail 
1:        3o10         15.0         2.0             121           136                  16                 SACSIN 
2:        1ufb          13.5         2.2            116           127                  16                 TT1696 PROTEIN 
3:        2q00         10.5         2.7            106           122                   14                ORF C02003 PROTEIN 
4:        3jyy          8.9         3.0            103           266        7 LINCOSAMIDE NUCLEOTIDYLTRANSFERASE 
5:        1kny         7.6         3.3            108           253              7         KANAMYCIN NUCLEOTIDYLTRANSFERASE 
6:        3agt             7.0        3.0             100         133                    5                  HEMERYTHRIN-LIKE DOMAIN PROTEIN 
 
Notably, the HEPN domain of VBP aligns with the C-terminal domain of kanamycin 
nucleotidyl transferase from Staphylococcus aureus (PDB code: 1KNY) with an rmsd of 
2.9 Ǻ for the 104 Cα atoms. Although VBP has very low sequence identity (14 to 16%) 






3.3.3. VBP is a dimer  
 
 The crystal structure of the HEPN domain shows the presence of a tight dimer in 
the asymmetric unit. The molecular mass calculated based on the sequence of VBP is 
37.5 kDa. However, the size exclusion chromatography showed that VBP elutes as a 
single peak at an elution volume corresponding to an apparent molecular mass of 75 kDa 
(Fig. 3.5).  
Fig. 3.5. Gel filtration profile of VBP.  Full length VBP elutes as a single peak (in 
green) at an elution volume corresponding to an apparent molecular mass of 75 kDa. The 
molecular weight standard is shown in red  
 
 Further AUC analysis showed that VBP sediments as a single species 
corresponding to an apparent molecular mass of dimeric VBP (75 kDa). Taken together, 
these results show that VBP forms a homodimer in solution (Fig. 3.6) and likely 







Fig. 3.6. AUC profile of VBP. Full length VBP sediments as a single species at an 
apparent molecular mass of 75kDa. 
 
3.3.4. HEPN domain of VBP is the dimerization domain 
 
We examined the role of the HEPN domain in VBP oligomerization by generating 
individual constructs for the N-terminal (NT) and C-terminal (HEPN) domains of VBP.  
The size-exclusion chromatography of the purified proteins showed that the NT domain 
elutes as a single peak at an elution volume corresponding to an apparent molecular mass 
of 16.8 kDa (NT as monomer), whereas the HEPN domain elutes as a single peak at an 
elution volume corresponding to an apparent molecular mass of 37 kDa (HEPN as a 
dimer) (Fig. 3.7). These results were further confirmed using analytical 
ultracentrifugation experiments (Fig. 3.8 and Fig. 3.9), and are consistent with the crystal 
structure findings that show the presence of a tight dimeric   HEPN domains in the 
asymmetric unit. Taken together, these results suggest that HEPN domain is responsible 





Fig. 3.7. Comparison of gel filtration profiles of NT domain and HEPN domain of 
VBP.  NT domain elutes as a single peak (in green) at an elution volume corresponding 
to an apparent molecular mass of 17 kDa while HEPN domain elutes as a single peak (in 
brown) at an elution volume corresponding to a molecular mass of 37 kDa. The 
molecular mass standard is shown in red.  
 
  
Fig. 3.8.  AUC  profile of HEPN domain of VBP. Wild type HEPN domain sediments 






Fig. 3.9. AUC  profile of NT domain of VBP. NT domain sediments as a major species 
at an apparent molecular mass of 17kDa. 
 
3.3.5. Substitution of Asn186 with Asp disrupts the dimerization  
 
The structural analysis indicates that the HEPN dimer is held together by the 
contacts maintained throughout the helices α1 and α2; in particular Asp173, Lys184 and 
Asn186 of the HEPN domain play an important role in holding the dimer. Asn186 is 
located at the edge of a loop which links the α1 and α2 helices of the dimer interface (Fig. 
3.3). Asn186, Lys184 and Asp173 of one monomer form hydrogen bonding contact with 
Asp173 and Asn186, Lys184 of the second monomer respectively. We substituted 
Asn186 with Asp in the HEPN domain and verified its oligomerization state by size 
exclusion chromatography and analytical ultracentrifugation experiments (Fig. 3.10 and 
Fig. 3.11).Both experiments show that HEPN Asn186Asp exists as a monomer in 
solution. These results indicate that substitution of Asn186Asp breaks the dimer. The 
secondary structure of HEPN and HEPN mutant was compared using circular dichroism 





Fig. 3.10. Comparison of gel filtration profiles of HEPN domain of VBP3.  HEPN 
domain elutes as a single peak (in brown) at an elution volume corresponding to an 
apparent molecular mass of 37 kDa while  HEPN domain with Asn186Asp elutes as a 
single peak (in blue) at an elution volume corresponding to a molecular mass of 18.5 
kDa. The molecular weight standard is shown in red. 
 
 
Fig. 3.11. AUC profile of HEPN N186D domain of VBP. HEPN domain with 







Fig. 3.12. CD spectroscopy of HEPN domain. HEPN domain and HEPN N186D 
 
Next we verified the role of Asn186 in the full length VBP. The substitution of Asn186 in 
VBP breaks the dimer and the protein elutes at a molecular mass of 37.5 kDa (Fig. 3.13).  
 
Fig. 3.13. Comparison of gel filtration profiles of VBP with/without substitution of 
N186D.VBP domain elutes (in green) at apparent molecular mass of 75 kDa while  VBP 
Asn186Asp elutes (in blue) at an elution volume corresponding to a molecular mass of 




Further AUC analysis of full length VBP with Asn186Asp, shows that the protein 
sediments as a single species corresponding to an apparent molecular mass of monomeric 
VBP (37.5 kDa) (Fig. 3.14). The circular dichroism (CD) spectrum of the wild-type and 
substituted VBP suggest that the mutants have the same fold as the wild-type proteins 
(Fig. 3.15).  
 
Fig. 3.14. AUC profile of VBP N186D. VBP with substitution Asn186Asp sediments as 
a single species at an apparent molecular mass of 37.5 kDa. 
Fig. 3.15. CD spectroscopy of VBP/VBP N186D. VBP with/without substitution at 




These results indicate that the two hydrogen bonds present at the core of the dimeric 
interface play a key role in holding the dimeric HEPN intact. Moreover these 
observations reiterate that HEPN domain is the dimerization domain of VBP. 
3.3.6. VBP functions as a dimer in vivo  
 
 Recruitment of the T-DNA complex to the CP is a key step in the T4SS, for 
which VBP plays a central role. The observed dimeric nature of VBP in solution and in 
the crystal structure prompted us to verify the functional state of VBP inside the cell 
using a plant virulence assay. A triple vbp null mutant strain GMI9017Δvbp2Δvbp3 (for 
which all three existing vbp genes were knocked out) was complemented with pQH300-
17 plasmid harboring substituted constructs for a functional vbp gene, a gene expressing 
the HEPN domain, and a gene expressing the NT domain. We found that null mutants 
transformed with a plasmid expressing VBP could cause a tumor-like phenotype in the 
wild-type plants (Fig. 3.16). Strains expressing a substituted VBP (VBPAsn186Asp) or one 
of the other deletion mutants (pQH-NTD or pQH-HEPN) did not cause tumors. These 
results indicate that VBP functions as a dimer in the cells and that full-length VBP is 






Fig. 3.16. The effect of VBP mutations on tumorigenesis. Agrobacterium. tumefaciens strains were grown in MG/L medium at 
28°C overnight. The cell density was adjusted to 10
8 
cells per milliliter. Then 5µl of cell suspension was inoculated onto each wound 





3.3.6. Interaction of VBP with ATP and VirD2 
 
Proteins homologous to VBP are predicted to bind ATP (Kozlov et al., 2011). A 
previously reported structure of kanamycin nucleotidyl transferase (PDB code: 1KNY), a 
structural homolog of VBP, in complex with an ATP analog and kanamycin, shows that 
the nucleotide binding pocket involves residues from the N-terminal domain of one 
monomer and the C-terminal domain of the second monomer. We verified the ATP 
binding property of VBP using ITC (Fig. 3.16 a, b Table 3.3). The ITC analysis shows 
that VBP binds to the ATP analog (AMPPNP) (Kd= 1.8 µM), whereas VBP with an 
Asn186Asp substitution does not bind to AMPPNP. These results indicate that only 
dimeric VBP binds to ATP. Further, we sought to verify whether VBP-HEPN domain 
alone can bind nucleotides using ITC experiments (Fig. 3.16c). Our results indicate that 
the HEPN domain alone cannot bind nucleotides. We infer that, similar to the kanamycin 
nucleotidyl transferase, the ATP binding in VBP might involve both N-terminal and C-
terminal domains. Notably, the structure of the kanamycin nucleotidyl transferase (PDB 
code: 1KNY) complexed with a nucleotide analog and kanamycin shows that the two 
monomers of the dimer interact in an anti-parallel fashion to form the ATP binding 
pocket. Similarly, the structure of the HEPN domain from VBP shows that the two HEPN 
monomers form a tight dimer in which the monomers run in anti-parallel. Although the 
relative orientation of monomers in the dimers of both proteins is not the same, both 






Fig. 3.17. ITC profile for VBP/ VBP N186D / HEPN domain vs. AMPPNP binding. The binding affinities of VBP/VBP 
N186D/HEPN domain to AMPPNP were determined using isothermal titration calorimetry (ITC). Representative ITC profiles are 
shown.




 Table 3.3: Stoichiometry, affinity and favorability of VBP vs. AMPPNP interactions 
 
 
VBP is the key recruiting protein that binds to VirD2-T-DNA-VirE2 complex and 
recruits it to the VirD4 CP for subsequent translocation to the host (Guo et al., 2007b). 
Thus, we finally sought to verify the VirD2 binding property of VBP using pull-down 
assays. We showed that VBP binds to VirD2, whereas VBP with an Asn186Asp 










Fig. 3.18. In vitro pull down assay. MBP/MBP-VirD2 bound to amylose resin was 
incubated overnight with 6His-VBP, followed by washes. The final beads were resolved 
in a 12.5% SDS-PAGE. The protein was transferred to a PVDF membrane and treated 
with Anti-His monoclonal antibody (1:10000). The PVDF membrane was examined 
using the SuperSignal WestPico Chemiluminescent substrate (Pierce Biotechnology; 
Rockford, IL, USA) under the conditions recommended by the manufacturer.6His-VBP 











VBP vs. AMPPNP 2.157 5.6 X 105 1.8 -7.97 -0.521 -7.45 
VBP N186D vs. AMPPNP No binding 




The results indicate that, similar to the nucleotide binding property, the VirD2 binding 
property also requires the dimeric nature of VBP, and thus the dimerization of VBP is 
essential for its function. 
3.4. Discussion 
 
A. tumefaciens causes crown gall disease in over 140 species of dicots (Moore et 
al., 1997), instigating infection through the efficient translocation of the T-DNA-protein 
complex (Alvarez-Martinez and Christie, 2009), a prerequisite for tumor formation in 
plants (Pitzschke and Hirt, 2010). T-DNA is a segment of the Ti plasmid between the 
right and left border sequences, and the Ti plasmid encodes most of the proteins that are 
involved in the T-DNA-protein complex, with each protein catering to a particular stage 
of the translocation process. The VirD4 CP is known to couple the T-DNA-protein 
complex (VBP-VirD2-VirE2) as a recruiting complex to the T4SS secretion apparatus. 
Of these three components, the VBP (VirD2 binding protein) is the key component of the 
recruiting complex (Guo et al., 2007).  
 VBP belongs to the class of HEPN domain–containing proteins that have a N-
terminal NT-domain and a C-terminal HEPN domain (Grynberg et al., 2003). Here we 
sought to analyze the structural and functional aspects of the HEPN domain of VBP. We 
show that HEPN domain facilitates dimerization of VBP, forming tight anti-parallel 
dimers. The structural similarity observed between the HEPN domain of VBP and 
kanamycin nucleotidyl transferase, in addition to the results from our ITC experiments, 
suggest that a nucleotide binding pocket is formed by the dimeric interface in this protein. 
Further, our pull-down assays show that only dimeric VBP can bind VirD2 and that 
















Fig. 3.19. Schematic representation shows the induction of tumor in plants by Agrobacterium and the role of VBP. Our 
experiments show that only dimeric VBP can bind to VirD2. Once VBP binds to VirD2 (steps 1 and 2), it recruits the VirD2-T-DNA-
VirE2 complex to the T4SS apparatus which constitutes the 11 VirB proteins (3). Guo et al have shown that VBP interacts with 
VirD4, VirB4 and VirB11 proteins independently. Once recruited to the T4SS apparatus the VirD2-T-DNA-VirE2 complex is 
translocated into the host cell cytoplasm (4). It is yet unclear whether VBP is translocated or not (Guo et al., 2007b). Inside the host 
cell, certain host cytoplasmic proteins recognize and bind to the nuclear localization signals on VirD2 and VirE2 and translocate the 
VirD2-T-DNA-VirE2 complex to the nucleus(5) (Zupan and Zambryski, 1995). Inside the nucleus VirD2 and VirE2 along with a 
plethora of host proteins help the T-DNA to integrate with the host DNA (6) (Citovsky et al., 2007). The integrated T-DNA modulates 




Based on the sequence analysis, it has been predicted that the NT domain of VBP 
belongs to the DNA polymerase β superfamily of proteins (Aravind and Koonin, 1999). 
This superfamily includes nucleotidyl transferases that catalyze nucleotidylation of 
proteins in yet unidentified pathways (Aravind and Koonin, 1999).  VBP binds to VirD2, 
VirD4, VirB4 and VirB11 energizing components of the T4SS (Guo et al., 2007b), which 
makes it difficult to predict the exact nucleotidylation site of the protein. However, based 
on our results, we propose that nucleotide binding to the dimeric VBP and its transfer to 
another as yet unknown protein in the translocation machinery are two essential steps in 
T-DNA translocation in this system. Furthermore, we are tempted to speculate that VBP 
acts as an ATP-driven shuttle that recruits the T-DNA-protein complex to the VirD4 CP. 
The present study sheds light on the role of VBP in the T-DNA-protein complex 
translocation in VirB/D4 T4SS of A. tumefaciens and other bacteria that use the Type IV 































































4.1. Conclusion  
 
This thesis reports the structural and functional characterization of two key 
secretion system components viz., GrlR-GrlA complex from the T3SS and HEPN domain 
of VBP from the T4SS. 
 A major infection mechanism employed by the AE pathogens like the EHEC and 
EPEC is the type III secretion system. T3SS is a syringe-like apparatus composed of 
approximately 20 proteins that serve to transfer virulence proteins from the bacteria 
directly into the host cytoplasm. The genes encoding for the T3SS components and 
related proteins are organized in several operons that are clustered in the locus of 
enterocyte effacement (LEE). GrlR-GrlA is a major regulatory complex of the T3SS. 
GrlA is a positive regulator of the LEE1 promoter and forms a positive regulatory loop 
with Ler. GrlR binds to GrlA and this is thought to account for the negative effect of 
GrlR on ler expression (Barba et al., 2005; Deng et al., 2004a; Iyoda et al., 2006). In 
addition to its function as a LEE1 regulator, GrlA negatively regulates the transcription of 
the flhDC operon and thus controls flagellar gene expression. Besides GrlA is implicated 
in the transcriptional activation of the ehxCABD operon in EHEC (Schmidt et al., 1995; 
Welch and Pellett, 1988). 
We reported the crystal structure of GrlAΔ (aa1-106) in complex with GrlR, 
refined to 2.7 Å resolution, along with the functional studies in the second chapter. The 
complex structure is asymmetric with a stoichiometry of 2 GrlR: 1 GrlAΔ. The crystal 
structure shows that GrlR binds to the HTH motif region of GrlA. ITC experiments with 
various constructs of GrlA /GrlAΔ with GrlR have shown that full length GrlA binds to 




region on GrlA that involves in binding GrlR. We verified the role of the key residues 
from the HTH motif in DNA binding using in vivo EspB secretion assay and ler-gfp 
promoter assay. Competitive EMSA studies revealed a novel regulatory mechanism by 
which GrlR interacts with GrlA at its Helix-Turn-Helix (HTH) motif, preventing GrlA 
from binding to its target promoter DNA. We also carried out EMSA with flhDC and 
ehxCABD promoters. Results from these assays show that GrlA binds with these 
promoters like it does with ler promoter. Furthermore GrlR can replace this promoter 
DNA from GrlA-DNA complex. Regulation of multiple virulence operons by a central 
heterotrimeric GrlR-GrlA complex would help the pathogen to precisely control the 
expression of various genes involved in its pathogenesis. By differentially regulating the 
ler and ehx operons positively and the flhDC operon negatively, GrlR and GrlA 
coordinate and optimize gene expression by the pathogen during the infection process. 
Further we studied the VirD2 binding protein (VBP) from Agrobacterium 
tumefaciens. A.tumefaciens harbors a T4SS. T4SS has unparalleled versatility among the 
known bacterial translocation systems. These systems export both DNA and protein 
substrates by cell-contact-dependent and cell-contact-independent mechanisms, and also 
import DNA from the extracellular milieu. The T4SS apparatus of A.tumefaciens 
comprise of the 11 VirB proteins which form the T4SS apparatus that translocates the 
VirD2-T-DNA-VirE2 complex to plant cells.  The coupling proteins (CP) mediate the 
interaction between the substrate and the transport apparatus. VirD4 acts as a coupling 
protein in A.tumefaciens. It could recruit VirE2 to the bacterial cell poles. VirD2 binding 




the VirD4 coupling protein. However, the molecular mechanism by which VBP recruits 
the complex is unknown.  
The crystal structure of the C-terminal domain of VBP determined to 2.8 Å along 
with the functional studies is reported in the third chapter. Sequence and structural 
analysis of the C-terminal domain have shown that it is homologous to the HEPN domain 
of Sacsin. HEPN domain forms dimer in solution as well as in the crystal consistent with 
VBP which forms dimer in solution. The NT domain however, is a monomer in solution 
clearly indicating that HEPN domain of VBP is the dimerization domain. The crystal 
structure showed that HEPN is a α-helical domain. The dimeric interface is kept intact by 
a two tethered contact between Asp-173 of one protomer and Asn-186 of the second 
protomer.  Using site-directed mutagenesis and Analytical ultracentrifugation we showed 
that substitution of Asn-186 with Asp, HEPN domain becomes monomer both in the 
HEPN domain and in the full length VBP. Moreover, virulence assay was performed to 
verify the functional form of VBP in Agrobacterium. Our results indicated that VBP is a 
functional dimer and that HEPN domain or the NT domain alone cannot cause tumor in 
the plants. This study sheds light into the molecular mechanism of T-DNA transfer to 
plants and this will lead to an effective treatment of crown gall disease in plants. 
In conclusion, the GrlR-GrlA structure and the DNA binding studies have 
demonstrated the regulatory mechanism involving Ler, GrlR and GrlA. Moreover, it 
revealed the unique synchronization the GrlR-GrlA complex brings into the regulation of 
multiple virulence operons thereby enhancing pathogenesis. The structure of HEPN 
domain of VBP and the structure based functional studies have revealed the importance 




following section, the future direction in which these projects could be pursued is 
discussed. 
4.2. Future directions 
 
ITC analysis of binding between GrlA/GrlAΔ and GrlR has shown that GrlA has 
more affinity to GrlR than does GrlAΔ, clearly indicating that the additional region from 
the C-terminus of GrlA contributes to increased affinity. Crystal structure of full length 
GrlR-GrlA complex will help to understand this additional contribution. 
Our EMSA analysis has shown that GrlA binds to the ler, flhDC and ehxCABD 
promoters in a similar fashion and involves the same residues from the HTH motif of 
GrlA; however, it positively regulates ler and ehxCABD promoters and negatively 
regulates flhDC. Crystal structure of GrlA with the promoter DNA can vividly explain 
these differences in modes of regulation of various promoters. 
Although we have verified the binding of GrlA with flhDC and ehxCABD using 
EMSA, an in vivo study like the motility assay and a toxin study would warrant a clear 
understanding of the phenotypic effects of the substitutions on GrlA. The plethora of 
proteins and the intricate networks involved make the system all the more complex to 
understand. An mRNA based quantitative RT-PCR to compare the mRNA levels of ler, 
flhDC and ehxCABD genes will help us understand the mode and the stage of regulation 
involved. 
The details from these studies will help to design drugs or vaccines that can target 
the protein secretion system. Since these drugs target the secretion system, they have a 





VBP is a key missing link in the T4SS recruitment pathway and is also involved 
in binding various key proteins that constitutes T-DNA-protein complex.  The 
prerequisite in understanding the molecular details of recognition is the establishment of 
interaction among the member proteins of the T4SS. The interaction of VirD2 with VBP 
has been established using co-immunoprecipitation. Previously, the physiological 
relevance of VirD4 CP (Coupling Protein) –VirD2 interaction has been verified by 
transfer DNA immunoprecipitation. As a continuation of our studies, the role of VBP in 
establishing the interaction between VirD4 CP and VirD2-T-DNA can be verified by 
forming a tertiary complex of the three proteins involved and determine the structure 
using X-ray crystallography and / or cryo-electron microscopy. 
Notably, studies in other systems of T4SS have shown that the CP translocates 
promiscuous plasmid clearly depicting that there is an underlying recognition mechanism 
that is conserved(Cascales, 2008). This mechanism can be well established only with the 
structure of the tertiary complex. Further, the interaction of VBP with the channel 
proteins can be verified by co-immunoprecipitation.    
VBP has independent binding with various other molecules of the T4SS. Structure 
determination, of various molecular (e.g. with VirD2, VirD4 etc.,) complexes with VBP 
can be carried out.  
Results from our current studies, in combination with those planned for the future, 
will provide a better understanding of the type III and type IV secretion systems. This 
will lead to the design of molecules which can block the secretion of virulence proteins. 
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Structure of GrlR–GrlA complex that prevents
GrlA activation of virulence genes
Abhilash Padavannil1, Chacko Jobichen1, Erez Mills2, Adrian Velazquez-Campoy3,4,5, Mo Li1, Ka Yin Leung6,7,
Yu Keung Mok1, Ilan Rosenshine2 & J. Sivaraman1
The locus of enterocyte effacement (LEE) is essential for virulence of enterohaemorrhagic
Escherichia coli (EHEC) and enteropathogenic E. coli (EPEC). The 41 genes of the LEE encode
type III secretion system proteins and three associated regulators: Ler, GrlA and GrlR. Ler is a
positive regulator for most of the LEE operons, including grlRA. GrlA controls the expression
of ler, ehxCABD and ﬂhDC operons. GrlR binds to GrlA and suppresses its function. Here we
report the crystal structure of GrlR–GrlAD (aa 1–106) complex (2:1) and its functional
characterization. We show that GrlR interacts with the Helix-Turn-Helix motif of GrlA.
Moreover, GrlA binds to the promoter DNA fragments of ler, ehxCABD and ﬂhDC, and GrlR
outcompetes with these promoter DNA sequences for the Helix-Turn-Helix motif of GrlA.
These ﬁndings provide mechanistic insight into a regulatory module for the virulence of EPEC
and EHEC, two important pathogens that cause devastating diseases.
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